"Assay ID - IEDB IRI","Reference - IEDB IRI","Reference - Type","Reference - PMID","Reference - Submission ID","Reference - Authors","Reference - Journal","Reference - Date","Reference - Title","Epitope - IEDB IRI","Epitope - Object Type","Epitope - Name","Epitope - Reference Name","Epitope - Modified residues","Epitope - Modifications","Epitope - Starting Position","Epitope - Ending Position","Epitope - IRI","Epitope - Synonyms","Epitope - Source Molecule","Epitope - Source Molecule IRI","Epitope - Molecule Parent","Epitope - Molecule Parent IRI","Epitope - Source Organism","Epitope - Source Organism IRI","Epitope - Species","Epitope - Species IRI","Epitope - Epitope Comments","Related Object - Epitope Relation","Related Object - Object Type","Related Object - Name","Related Object - Starting Position","Related Object - Ending Position","Related Object - IRI","Related Object - Synonyms","Related Object - Source Molecule","Related Object - Source Molecule IRI","Related Object - Molecule Parent","Related Object - Molecule Parent IRI","Related Object - Source Organism","Related Object - Source Organism IRI","Related Object - Species","Related Object - Species IRI","Host - Name","Host - IRI","Host - Geolocation","Host - Geolocation IRI","Host - Sex","Host - Age","Host - MHC Present","1st in vivo Process - Process Type","1st in vivo Process - Disease","1st in vivo Process - Disease IRI","1st in vivo Process - Disease Stage","1st immunogen - Epitope Relation","1st immunogen - Object Type","1st immunogen - Name","1st immunogen - Reference Name","1st immunogen - Starting Position","1st immunogen - Ending Position","1st immunogen - IRI","1st immunogen - Source Molecule","1st immunogen - Source Molecule IRI","1st immunogen - Molecule Parent","1st immunogen - Molecule Parent IRI","1st immunogen - Source Organism","1st immunogen - Source Organism IRI","1st immunogen - Species","1st immunogen - Species IRI","1st immunogen - Adjuvants","1st immunogen - Route","1st immunogen - Dose Schedule","2nd in vivo Process - Process Type","2nd in vivo Process - Disease","2nd in vivo Process - Disease IRI","2nd in vivo Process - Disease Stage","2nd immunogen - Epitope Relation","2nd immunogen - Object Type","2nd immunogen - Name","2nd immunogen - Reference Name","2nd immunogen - Starting Position","2nd immunogen - Ending Position","2nd immunogen - IRI","2nd immunogen - Source Molecule","2nd immunogen - Source Molecule IRI","2nd immunogen - Molecule Parent","2nd immunogen - Molecule Parent IRI","2nd immunogen - Source Organism","2nd immunogen - Source Organism IRI","2nd immunogen - Species","2nd immunogen - Species IRI","2nd immunogen - Adjuvants","2nd immunogen - Route","2nd immunogen - Dose Schedule","In vitro Process - Process Type","in vitro Responder Cell - Name","in vitro Responder Cell - IRI","in vitro Stimulator Cell - Name","in vitro Stimulator Cell - IRI","in vitro immunogen - Epitope Relation","in vitro immunogen - Object Type","in vitro immunogen - Name","in vitro immunogen - Reference Name","in vitro immunogen - Starting Position","in vitro immunogen - Ending Position","in vitro immunogen - IRI","in vitro immunogen - Source Molecule","in vitro immunogen - Source Molecule IRI","in vitro immunogen - Molecule Parent","in vitro immunogen - Molecule Parent IRI","in vitro immunogen - Source Organism","in vitro immunogen - Source Organism IRI","in vitro immunogen - Species","in vitro immunogen - Species IRI","Adoptive Transfer - Flag","Adoptive Transfer - Comments","Immunization - Comments","Assay - Location of Assay Data in Reference","Assay - Method","Assay - Response measured","Assay - Units","Assay - IRI","Assay - Qualitative Measurement","Assay - Measurement Inequality","Assay - Quantitative measurement","Assay - Number of Subjects Tested","Assay - Number of Subjects Positive","Assay - Response Frequency (%)","Assay - Comments","Effector Cell - Source Tissue","Effector Cell - Source Tissue IRI","Effector Cell - Name","Effector Cell - IRI","Effector Cell - Culture Condition","Effector Cell - TCR Name","Complex - PDB ID","Antigen Presenting Cell - Source Tissue","Antigen Presenting Cell - Source Tissue IRI","Antigen Presenting Cell - Name","Antigen Presenting Cell - IRI","Antigen Presenting Cell - Culture Condition","MHC Restriction - Name","MHC Restriction - IRI","MHC Restriction - Evidence Code","MHC Restriction - Evidence IRI","MHC Restriction - Class","Assay Antigen - Epitope Relation","Assay Antigen - Object Type","Assay Antigen - Name","Assay Antigen - Reference Name","Assay Antigen - Starting Position","Assay Antigen - Ending Position","Assay Antigen - IRI","Assay Antigen - Source Molecule","Assay Antigen - Source Molecule IRI","Assay Antigen - Molecule Parent","Assay Antigen - Molecule Parent IRI","Assay Antigen - Source Organism","Assay Antigen - Source Organism IRI","Assay Antigen - Species","Assay Antigen - Species IRI"
http://www.iedb.org/assay/5556,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/9351,"Linear peptide",DMAIVTLKVFAVVGL,"GagMA 81–95",,,81,95,,,"gag protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAP51393.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,229,8,1,12.5,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",DMAIVTLKVFAVVGL,,81,95,,"gag protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAP51393.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5557,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/5599,"Linear peptide",AVVGLLNMTVSTAAA,"GagMA 91–105",,,91,105,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/Q05313.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,38,8,1,12.5,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",AVVGLLNMTVSTAAA,,91,105,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/Q05313.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5558,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/35133,"Linear peptide",LDEELKQLTAEYDRT,"GagCA 203–217",,,,,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002745,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,98,8,1,12.5,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",LDEELKQLTAEYDRT,,,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002745,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5559,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/14988,"Linear peptide",EYDRTHPPDGPRPLP,"GagCA 213–227",,,213,227,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,51,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EYDRTHPPDGPRPLP,,213,227,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5560,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/12522,"Linear peptide",EIMGIGLTQEQQAEA,"GagCA 233–247",,,233,247,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,44,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EIMGIGLTQEQQAEA,,233,247,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5561,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/2562,"Linear peptide",ALGKLAAIKAKSPRA,"GagCA 263–277",,,263,277,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",ALGKLAAIKAKSPRA,,263,277,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5562,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/18636,"Linear peptide",GAKEDYSSFIDRLFA,"GagCA 283–297",,,283,297,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",GAKEDYSSFIDRLFA,,283,297,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5565,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/10002,"Linear peptide",DRLFAQIDQEQNTAE,"GagCA 293–307",,,293,307,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",DRLFAQIDQEQNTAE,,293,307,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5569,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/51048,"Linear peptide",QIDQEQNTAEVKLYL,"GagCA 298–312",,,298,312,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QIDQEQNTAEVKLYL,,298,312,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5570,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/21718,"Linear peptide",GPNQTCMWNTSQIQD,"EnvSU 156–170",,,156,170,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",GPNQTCMWNTSQIQD,,156,170,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5571,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/52190,"Linear peptide",QRAYYKNCKWEKTDV,"EnvSU 181–196",,,2,16,,,"envelope protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAQ11407.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,84,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QRAYYKNCKWEKTDV,,2,16,,"envelope protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAQ11407.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5572,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/5665,"Linear peptide",AWIEFGCHRNKSKLH,"EnvSU 261–275",,,439,453,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,28,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",AWIEFGCHRNKSKLH,,439,453,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5573,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/10301,"Linear peptide",DTCGNTQNVSGANPV,"EnvSU 296–110",,,108,122,,,"envelope glycoprotein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO27589.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,74,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",DTCGNTQNVSGANPV,,108,122,,"envelope glycoprotein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO27589.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5574,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/41013,"Linear peptide",MACPNNQGILRNWYN,"EnvSU 381–395",,,,,,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope occurred in cultures depleted of either CD4+ or CD8+, suggesting these epitopes are recognized by both T-cell subsets. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",MACPNNQGILRNWYN,,,,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5575,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/55093,"Linear peptide",RNWYNPVAGLRQSLE,"EnvSU 391–405",,,570,584,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,98,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",RNWYNPVAGLRQSLE,,570,584,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5576,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/52914,"Linear peptide",QYHQVLATHQEAIEK,"EnvTM 461–475",,,641,655,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QYHQVLATHQEAIEK,,641,655,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5577,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/31548,"Linear peptide",KKGIQQLQKWEDWVG,"EnvTM 581–596",,,761,775,,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected. The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",KKGIQQLQKWEDWVG,,761,775,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5578,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/11475,"Linear peptide",EDWVGWIGNIPQYLK,"EnvTM 591–605",,,593,607,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Negative,,,1,0,0,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EDWVGWIGNIPQYLK,,593,607,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5579,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/23297,"Linear peptide",GWVLSPLIYQSTLDN,"RT 151–165",,,311,325,,,"pol [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO69453.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,61,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",GWVLSPLIYQSTLDN,,311,325,,"pol [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO69453.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5580,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/48374,"Linear peptide",PLIYQSTLDNIIQPF,"RT 156–170",,,312,326,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",PLIYQSTLDNIIQPF,,312,326,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5581,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/61712,"Linear peptide",STLDNIIQPFIRQNP,"RT 161–175",,,317,331,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,31,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",STLDNIIQPFIRQNP,,317,331,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5582,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/26646,"Linear peptide",IIQPFIRQNPELDIY,"RT 166–180",,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002506,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,74,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",IIQPFIRQNPELDIY,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002506,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5583,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/12984,"Linear peptide",ELDIYQYMDDIYIGS,"RT 176–190",,,331,345,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,14,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",ELDIYQYMDDIYIGS,,331,345,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5584,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/29594,"Linear peptide",IYIGSNLSKKEHKEK,"RT 186–200",,,342,356,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was significantly reduced in the CD8+ depleted cultures, indicating this epitope is predominantly recognized by CD8+ cell, although some CD4+ activity was detected.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",IYIGSNLSKKEHKEK,,342,356,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5585,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/12544,"Linear peptide",EIPERPTLNELQKLA,"RT 246–260",,,401,415,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,18,1,1,100,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EIPERPTLNELQKLA,,401,415,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5587,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/71388,"Linear peptide",VTKKLEKEKAIRIFV,"OrfA 11–25",,,,,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Negative,,,1,0,0,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools.  The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",VTKKLEKEKAIRIFV,,,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/5588,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/18492,"Linear peptide",FYYWQLQSTLSITTA,"OrfA 64–78",,,64,78,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Negative,,,1,0,0,"This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted. Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted.The cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",FYYWQLQSTLSITTA,,64,78,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/6231,http://www.iedb.org/reference/637,Literature,15327905,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2004,"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.",http://www.iedb.org/epitope/18136,"Linear peptide",FVDRLLSQI,"gag 288-296",,,288,296,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus PV",https://ontology.iedb.org/ontology/ONTIE_0000408,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Minimal epitope.",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-W11 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus PV",,,,,,,,,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"Infected with single dose of 300 TCID50 of EIAVPV",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,,,,,,,,,,,,,,,,N,,,"Table 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",FVDRLLSQI,"gag 288-296",288,296,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/6232,http://www.iedb.org/reference/637,Literature,15327905,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2004,"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.",http://www.iedb.org/epitope/54770,"Linear peptide",RLSQIKSEG,"gag 291-300",,,,,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Minimal epitope.",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"Infected with single dose of 300 TCID50 of EIAVPV",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,,,,,,,,,,,,,,,,N,,,"Table 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",RLSQIKSEG,"gag 291-300",,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/6233,http://www.iedb.org/reference/637,Literature,15327905,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2004,"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.",http://www.iedb.org/epitope/75276,"Linear peptide",YPEFVDRLLS,"gag 285-294",,,285,294,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Minimal epitope.",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"Infected with single dose of 300 TCID50 of EIAVPV",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,,,,,,,,,,,,,,,,N,,,"Table 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",YPEFVDRLLS,"gag 285-294",285,294,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/8906,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/9351,"Linear peptide",DMAIVTLKVFAVVGL,"GagMA 81–95",,,81,95,,,"gag protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAP51393.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",DMAIVTLKVFAVVGL,,81,95,,"gag protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAP51393.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8907,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/5599,"Linear peptide",AVVGLLNMTVSTAAA,"GagMA 91–105",,,91,105,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/Q05313.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",AVVGLLNMTVSTAAA,,91,105,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/Q05313.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8908,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/35133,"Linear peptide",LDEELKQLTAEYDRT,"GagCA 203–217",,,,,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002745,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",LDEELKQLTAEYDRT,,,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002745,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8909,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/14988,"Linear peptide",EYDRTHPPDGPRPLP,"GagCA 213–227",,,213,227,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EYDRTHPPDGPRPLP,,213,227,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8910,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/12522,"Linear peptide",EIMGIGLTQEQQAEA,"GagCA 233–247",,,233,247,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EIMGIGLTQEQQAEA,,233,247,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8911,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/2562,"Linear peptide",ALGKLAAIKAKSPRA,"GagCA 263–277",,,263,277,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",ALGKLAAIKAKSPRA,,263,277,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8912,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/18636,"Linear peptide",GAKEDYSSFIDRLFA,"GagCA 283–297",,,283,297,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",GAKEDYSSFIDRLFA,,283,297,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8913,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/10002,"Linear peptide",DRLFAQIDQEQNTAE,"GagCA 293–307",,,293,307,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",DRLFAQIDQEQNTAE,,293,307,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8914,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/51048,"Linear peptide",QIDQEQNTAEVKLYL,"GagCA 298–312",,,298,312,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QIDQEQNTAEVKLYL,,298,312,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P16087.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8915,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/21718,"Linear peptide",GPNQTCMWNTSQIQD,"EnvSU 156–170",,,156,170,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",GPNQTCMWNTSQIQD,,156,170,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8916,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/52190,"Linear peptide",QRAYYKNCKWEKTDV,"EnvSU 181–196",,,2,16,,,"envelope protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAQ11407.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QRAYYKNCKWEKTDV,,2,16,,"envelope protein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAQ11407.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8917,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/5665,"Linear peptide",AWIEFGCHRNKSKLH,"EnvSU 261–275",,,439,453,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",AWIEFGCHRNKSKLH,,439,453,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8918,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/10301,"Linear peptide",DTCGNTQNVSGANPV,"EnvSU 296–110",,,108,122,,,"envelope glycoprotein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO27589.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",DTCGNTQNVSGANPV,,108,122,,"envelope glycoprotein [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO27589.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8919,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/41013,"Linear peptide",MACPNNQGILRNWYN,"EnvSU 381–395",,,,,,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",MACPNNQGILRNWYN,,,,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8920,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/55093,"Linear peptide",RNWYNPVAGLRQSLE,"EnvSU 391–405",,,570,584,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",RNWYNPVAGLRQSLE,,570,584,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/Q04993.1,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8921,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/52914,"Linear peptide",QYHQVLATHQEAIEK,"EnvTM 461–475",,,641,655,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QYHQVLATHQEAIEK,,641,655,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8922,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/31548,"Linear peptide",KKGIQQLQKWEDWVG,"EnvTM 581–596",,,761,775,,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",KKGIQQLQKWEDWVG,,761,775,,"envelope polyprotein [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002064,"Env protein",http://www.uniprot.org/uniprot/Q66014,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8923,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/11475,"Linear peptide",EDWVGWIGNIPQYLK,"EnvTM 591–605",,,593,607,,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EDWVGWIGNIPQYLK,,593,607,,"Envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/P87682,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8924,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/23297,"Linear peptide",GWVLSPLIYQSTLDN,"RT 151–165",,,311,325,,,"pol [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO69453.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each.  Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",GWVLSPLIYQSTLDN,,311,325,,"pol [Feline immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/ABO69453.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8925,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/61712,"Linear peptide",STLDNIIQPFIRQNP,"RT 161–175",,,317,331,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",STLDNIIQPFIRQNP,,317,331,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8926,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/26646,"Linear peptide",IIQPFIRQNPELDIY,"RT 166–180",,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002506,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",IIQPFIRQNPELDIY,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002506,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8927,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/12984,"Linear peptide",ELDIYQYMDDIYIGS,"RT 176–190",,,331,345,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",ELDIYQYMDDIYIGS,,331,345,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8928,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/29594,"Linear peptide",IYIGSNLSKKEHKEK,"RT 186–200",,,342,356,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",IYIGSNLSKKEHKEK,,342,356,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P19028.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8929,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/12544,"Linear peptide",EIPERPTLNELQKLA,"RT 246–260",,,401,415,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EIPERPTLNELQKLA,,401,415,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31822.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P16088,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8930,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/64797,"Linear peptide",TLFNKVTKKLEKEKA,"OrfA 6–20",,,,,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Table 2, Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,1,1,100,"The lymph node mononuclear cells used in the assay were from a single cat that was found to have broad reactivity to the individual peptides selected for the gene-specific pools. The other 7 subjects were not evaluated..  This assay was performed in lymph node mononuclear cells which were either CD8+ or CD4+ depleted.  Reactivity to this epitope was completely abrogated in the CD8+ depleted cultures, indicating this epitope is CD8+ restricted. This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",TLFNKVTKKLEKEKA,,,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8931,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/71388,"Linear peptide",VTKKLEKEKAIRIFV,"OrfA 11–25",,,,,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",VTKKLEKEKAIRIFV,,,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/8932,http://www.iedb.org/reference/602,Literature,15182995,,"Gregg A Dean; Alora LaVoy; Mary Jo Burkhard","Vet Immunol Immunopathol",2004,"Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.",http://www.iedb.org/epitope/18492,"Linear peptide",FYYWQLQSTLSITTA,"OrfA 64–78",,,64,78,,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"The cats in this study were infected with the FIV molecular clone NCSU1.",,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Feline immunodeficiency virus (feline immunodeficiency virus FIV)","FIV molecular clone NCSU1",,,,,,,,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,intravenous,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Eight cats infected by intravenous route with the Feline Immunodeficiency Virus molecular clone NCSU1 for 1-2 years.","Figure 2",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"This peptide was screened with PBMC from eight FIV+ cats in 34 preliminary peptide pools of 7-10 peptides each. Those that stimulated a T-cell response in at least one FIV+ cat were included in subsequent peptide analyses.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,Lymphocyte,http://purl.obolibrary.org/obo/CL_0000542,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",FYYWQLQSTLSITTA,,64,78,,"hypothetical protein FIVgp4 [Feline immunodeficiency virus]",https://ontology.iedb.org/ontology/ONTIE_0002063,"Probable Vpr-like protein",http://www.uniprot.org/uniprot/Q66013,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/15458,http://www.iedb.org/reference/637,Literature,15327905,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2004,"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.",http://www.iedb.org/epitope/41560,"Linear peptide",MGDPLTWSKALKKLEKVTVQGSQKLTTGNCNWALS,"EC 1 (MA 1-35)",,,1,35,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"Infected with single dose of 300 TCID50 of EIAVPV",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",MGDPLTWSKALKKLEKVTVQGSQKLTTGNCNWALS,,1,35,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Table 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,2,25,"ELA-A types of two responding horses were A1 and one undetermined (tested negative for A1-A10 and W11).",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",MGDPLTWSKALKKLEKVTVQGSQKLTTGNCNWALS,"EC 1 (MA 1-35)",1,35,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/15459,http://www.iedb.org/reference/637,Literature,15327905,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2004,"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.",http://www.iedb.org/epitope/56229,"Linear peptide",RTWWAISAVKMGLQINNVVDGKASFQLLRAKYEKKTANKKQSE,"EC 2 (MA 77-119)",,,77,119,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-A1 class I;ELA-W11 class I;ELA-A6 class I;ELA-A9 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"Infected with single dose of 300 TCID50 of EIAVPV",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RTWWAISAVKMGLQINNVVDGKASFQLLRAKYEKKTANKKQSE,,77,119,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Table 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,6,75,"Each horse tested in this assay had a unique set of MHC Class I alleles.  The allele from one horse was undetermined (tested negative for A1-A10 and W11).",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",RTWWAISAVKMGLQINNVVDGKASFQLLRAKYEKKTANKKQSE,"EC 2 (MA 77-119)",77,119,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/15470,http://www.iedb.org/reference/637,Literature,15327905,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2004,"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.",http://www.iedb.org/epitope/18638,"Linear peptide",GAKEPYPEFVDRLLSQIKSEGHPQEISKFLTD,"EC 3 (CA 156-187)",,,280,311,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-A1 class I;ELA-W11 class I;ELA-A9 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"Infected with single dose of 300 TCID50 of EIAVPV",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GAKEPYPEFVDRLLSQIKSEGHPQEISKFLTD,,280,311,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Table 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,5,62.5,"Each horse tested in this assay had a unique set of MHC Class I alleles.  The allele from one horse was undetermined (tested negative for A1-A10 and W11).",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",GAKEPYPEFVDRLLSQIKSEGHPQEISKFLTD,"EC 3 (CA 156-187)",280,311,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/15472,http://www.iedb.org/reference/637,Literature,15327905,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2004,"CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.",http://www.iedb.org/epitope/51668,"Linear peptide",QNANEECRNAMRHLRPEDTLEEKMYACRDIGTTKQKMMLL,"EC 4 (CA 192-232)",,,316,355,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-A6 class I;ELA-A9 class I;ELA-A3 class I;ELA-A5 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"Infected with single dose of 300 TCID50 of EIAVPV",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",QNANEECRNAMRHLRPEDTLEEKMYACRDIGTTKQKMMLL,,316,355,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Table 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,4,50,"Each horse tested in this assay had a unique set of MHC Class I alleles.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",QNANEECRNAMRHLRPEDTLEEKMYACRDIGTTKQKMMLL,"EC 4 (CA 192-232)",316,355,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1347074,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/30731,"Linear peptide",KFGAEVVPGFQALSEGCTPYDINQMLNCVGD,GAG165-195,,,165,195,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05893.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KFGAEVVPGFQALSEGCTPYDINQMLNCVGD,GAG165-195,165,195,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05893.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",KFGAEVVPGFQALSEGCTPYDINQMLNCVGD,,165,195,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05893.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,8,0,0,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KFGAEVVPGFQALSEGCTPYDINQMLNCVGD,GAG165-195,165,195,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05893.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347088,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/76218,"Linear peptide",YTYEAYARYPEELEASQACQRKRLEEG,Nef221-247,,,221,247,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",YTYEAYARYPEELEASQACQRKRLEEG,Nef221-247,221,247,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",YTYEAYARYPEELEASQACQRKRLEEG,,221,247,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,8,0,0,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",YTYEAYARYPEELEASQACQRKRLEEG,Nef221-247,221,247,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347089,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/51130,"Linear peptide",QIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTN,GAG246-281,,,246,282,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"There is one additional residue for this epitope from cited reference by I. Bourgault, et al. (J Immunol., 1994; 152:2530-7).",,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",QIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTN,GAG246-281,246,282,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",QIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTN,,246,282,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,3,37.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",QIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPTN,GAG246-281,246,282,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347092,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/62316,"Linear peptide",SVRPKVPLRA,Nef101-110,,,101,110,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",SVRPKVPLRA,Nef101-110,101,110,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",SVRPKVPLRA,,101,110,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,1,12.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Fragment of Source Antigen","Linear peptide",SVRPKVPLRAMTYKMAIDMSHFIKEK,Nef101-126,101,126,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347093,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/1877,"Linear peptide",AIDMSHFIKEK,Nef116-126,,,116,126,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SVRPKVPLRAMTYKMAIDMSHFIKEK,Nef101-126,101,126,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",SVRPKVPLRAMTYKMAIDMSHFIKEK,,101,126,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,2,25,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",AIDMSHFIKEK,Nef116-126,116,126,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347094,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/20815,"Linear peptide",GLEGIYYSA,Nef128-136,,,128,136,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",EKGGLEGIYYSARRHRILDIYLE,Nef125-147,125,147,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",EKGGLEGIYYSARRHRILDIYLE,,125,147,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,3,37.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",GLEGIYYSA,Nef128-136,128,136,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347096,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/33665,"Linear peptide",KTFGWLWKLV,Nef169-178,,,169,178,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",DWQDYTFGPGIRYPKTFGWLWKLV,Nef155-178,155,178,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",DWQDYTFGPGIRYPKTFGWLWKLV,,155,178,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,3,37.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KTFGWLWKLV,Nef169-178,169,178,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347097,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/58966,"Linear peptide",SKWDDPWGEVL,Nef201-211,,,201,211,,,"NEF protein",http://www.ncbi.nlm.nih.gov/protein/CAC22286.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",SKWDDPWGEVLAWKFDPTLAYTYEA,Nef201-225,201,225,,"NEF protein",http://www.ncbi.nlm.nih.gov/protein/CAC22286.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",SKWDDPWGEVLAWKFDPTLAYTYEA,,201,225,,"NEF protein",http://www.ncbi.nlm.nih.gov/protein/CAC22286.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,1,12.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SKWDDPWGEVL,Nef201-211,201,211,,"NEF protein",http://www.ncbi.nlm.nih.gov/protein/CAC22286.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347098,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/35020,"Linear peptide",LAWKFDPTL,Nef211-219,,,211,219,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",AKWDDPWGEVLAWKFDPTLAYTYEA,Nef201-225,201,225,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",AKWDDPWGEVLAWKFDPTLAYTYEA,,201,225,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,1,12.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LAWKFDPTL,Nef211-219,211,219,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347099,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/15444,"Linear peptide",FDPTLAYTYEA,Nef215-225,,,215,225,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",AKWDDPWGEVLAWKFDPTLAYTYEA,Nef201-225,201,225,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",AKWDDPWGEVLAWKFDPTLAYTYEA,,201,225,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,1,12.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",FDPTLAYTYEA,Nef215-225,215,225,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25490.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347107,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/72646,"Linear peptide",WIQLGLQKCV,GAG266-275,,,266,275,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",QIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPT,GAG246-281,246,281,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",QIQWMYRQQNPIPVGNIYRRWIQLGLQKCVRMYNPT,,246,281,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2 and Table 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,1,12.5,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",WIQLGLQKCV,GAG266-275,266,275,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05894.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1347108,http://www.iedb.org/reference/1003065,Literature,10196344,,"L Mortara; H Gras-Masse; C Rommens; A Venet; J G Guillet; I Bourgault-Villada","J Virol",1999,"Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques.",http://www.iedb.org/epitope/12692,"Linear peptide",EKGGLEGIYYSARRHRILDMYLE,Nef125-147,,,125,147,,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",EKGGLEGIYYSARRHRILDMYLE,Nef125-147,125,147,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,subcutaneous,"Three injections with 500 µg of each lipopeptides s.c. at 1-month intervals.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro","T cell",http://purl.obolibrary.org/obo/CL_0000084,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",EKGGLEGIYYSARRHRILDMYLE,,125,147,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Monkeys were immunized with 500 µg of tetanus toxoid in IFA (3 s.c. and one i.m.) at one month intervals. Seven months later, animals were given three additional injections s.c. of a mixture of lipopeptide micelle (500 µg of each) at 1-month intervals.  PBMC from immunized animals were cultured with a mixture of 10 µM of each free long peptides for 3 days followed by addition of IL-2. CTL were restimulated with peptide-pulsed irradiated autologous PBMC weekly.","Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,8,4,50,"CTL lines were derived from monkeys immunized with tetanus toxoid and mixture of long lipopeptides which the C-terminus were palmitoylated with Nε-palmitoyl-lysylamide. Specific killing was measured against free long peptides and overlapping short peptides (8-11 aa) to identify the epitope. Animals responded to the Th epitope TT830-846 elicited stronger and more CTL lines against multiple epitopes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",,,Lymphoid,http://purl.obolibrary.org/obo/UBERON_0001744,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EKGGLEGIYYSARRHRILDMYLE,Nef125-147,125,147,,"nef protein",http://www.ncbi.nlm.nih.gov/protein/AAD25504.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1435925,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/42993,"Linear peptide",MVSIAFYGGIPGGISTPITQ,"EIAV (UK) Env",,,1,20,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",MVSIAFYGGIPGGISTPITQ,"EIAV (UK) Env",1,20,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435931,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47665,"Linear peptide",PGGISTPITQQSEKSKCEEN,"EIAV (UK) Env",,,11,30,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",PGGISTPITQQSEKSKCEEN,"EIAV (UK) Env",11,30,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435932,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/52310,"Linear peptide",QSEKSKCEENTMFQPYCYNN,"EIAV (UK) Env",,,21,40,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",QSEKSKCEENTMFQPYCYNN,"EIAV (UK) Env",21,40,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435933,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/65201,"Linear peptide",TMFQPYCYNNDSKNSMAESK,"EIAV (UK) Env",,,31,50,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",TMFQPYCYNNDSKNSMAESK,"EIAV (UK) Env",31,50,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435934,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/10156,"Linear peptide",DSKNSMAESKEARDQEMNLK,"EIAV (UK) Env",,,41,60,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",DSKNSMAESKEARDQEMNLK,"EIAV (UK) Env",41,60,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435935,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11179,"Linear peptide",EARDQEMNLKEESKEEKRRN,"EIAV (UK) Env",,,51,70,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",EARDQEMNLKEESKEEKRRN,"EIAV (UK) Env",51,70,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435936,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11878,"Linear peptide",EESKEEKRRNDWWKIGMFLL,"EIAV (UK) Env",,,61,80,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,8,66.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",EESKEEKRRNDWWKIGMFLL,"EIAV (UK) Env",61,80,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435937,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/10836,"Linear peptide",DWWKIGMFLLCLAGTTGGIL,"EIAV (UK) Env",,,71,90,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",DWWKIGMFLLCLAGTTGGIL,"EIAV (UK) Env",71,90,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435938,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/6537,"Linear peptide",CLAGTTGGILWWYEGLPQQH,"EIAV (UK) Env",,,81,100,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,10,83.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",CLAGTTGGILWWYEGLPQQH,"EIAV (UK) Env",81,100,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435939,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/73255,"Linear peptide",WWYEGLPQQHYIGLVAIGGR,"EIAV (UK) Env",,,91,110,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",WWYEGLPQQHYIGLVAIGGR,"EIAV (UK) Env",91,110,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435940,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/74218,"Linear peptide",YIGLVAIGGRLNGSGQSNAI,"EIAV (UK) Env",,,101,120,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",YIGLVAIGGRLNGSGQSNAI,"EIAV (UK) Env",101,120,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435941,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/38223,"Linear peptide",LNGSGQSNAIECWGSFPGCR,"EIAV (UK) Env",,,111,130,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",LNGSGQSNAIECWGSFPGCR,"EIAV (UK) Env",111,130,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435942,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11274,"Linear peptide",ECWGSFPGCRPFQNYFSYET,"EIAV (UK) Env",,,121,140,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ECWGSFPGCRPFQNYFSYET,"EIAV (UK) Env",121,140,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435943,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47555,"Linear peptide",PFQNYFSYETNRSMHMDNNT,"EIAV (UK) Env",,,131,150,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",PFQNYFSYETNRSMHMDNNT,"EIAV (UK) Env",131,150,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435944,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/45737,"Linear peptide",NRSMHMDNNTATLLEAYHRE,"EIAV (UK) Env",,,141,160,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",NRSMHMDNNTATLLEAYHRE,"EIAV (UK) Env",141,160,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435945,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/5037,"Linear peptide",ATLLEAYHREITFIYKSSCT,"EIAV (UK) Env",,,151,170,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ATLLEAYHREITFIYKSSCT,"EIAV (UK) Env",151,170,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435946,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/28895,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,"EIAV (UK) Env",,,161,180,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,"EIAV (UK) Env",161,180,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435947,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/10092,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,"EIAV (UK) Env",,,171,190,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,"EIAV (UK) Env",171,190,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435948,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/31731,"Linear peptide",KKVNLNSSDSSNPVRVEDVM,"EIAV (UK) Env",,,181,200,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KKVNLNSSDSSNPVRVEDVM,"EIAV (UK) Env",181,200,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435949,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/59882,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EIAV (UK) Env",,,191,210,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EIAV (UK) Env",191,210,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435950,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/46279,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EIAV (UK) Env",,,201,220,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EIAV (UK) Env",201,220,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435951,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/35372,"Linear peptide",LECNQTENFKTILVPENEMV,"EIAV (UK) Env",,,211,230,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",LECNQTENFKTILVPENEMV,"EIAV (UK) Env",211,230,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435952,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/64372,"Linear peptide",TILVPENEMVNINDTDTWIP,"EIAV (UK) Env",,,221,240,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",TILVPENEMVNINDTDTWIP,"EIAV (UK) Env",221,240,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435953,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44295,"Linear peptide",NINDTDTWIPKGCNETWARV,"EIAV (UK) Env",,,231,250,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",NINDTDTWIPKGCNETWARV,"EIAV (UK) Env",231,250,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435954,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/30904,"Linear peptide",KGCNETWARVKRCPIDILYG,"EIAV (UK) Env",,,241,260,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",KGCNETWARVKRCPIDILYG,"EIAV (UK) Env",241,260,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435955,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/33114,"Linear peptide",KRCPIDILYGIHPIRLCVQP,"EIAV (UK) Env",,,251,270,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",KRCPIDILYGIHPIRLCVQP,"EIAV (UK) Env",251,270,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435956,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/26399,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EIAV (UK) Env",,,261,280,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EIAV (UK) Env",261,280,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435957,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47490,"Linear peptide",PFFLVQEKGIANTSRIGNCG,"EIAV (UK) Env",,,271,290,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",PFFLVQEKGIANTSRIGNCG,"EIAV (UK) Env",271,290,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435958,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/3430,"Linear peptide",ANTSRIGNCGPTIFLGVLED,"EIAV (UK) Env",,,281,300,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ANTSRIGNCGPTIFLGVLED,"EIAV (UK) Env",281,300,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435959,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/49664,"Linear peptide",PTIFLGVLEDNKGVVRGNYT,"EIAV (UK) Env",,,291,310,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",PTIFLGVLEDNKGVVRGNYT,"EIAV (UK) Env",291,310,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435966,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44499,"Linear peptide",NKGVVRGNYTACNVSRLKIN,"EIAV (UK) Env",,,301,320,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",NKGVVRGNYTACNVSRLKIN,"EIAV (UK) Env",301,320,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435967,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/583,"Linear peptide",ACNVSRLKINRKDYTGIYQV,"EIAV (UK) Env",,,311,330,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ACNVSRLKINRKDYTGIYQV,"EIAV (UK) Env",311,330,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435968,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/54336,"Linear peptide",RKDYTGIYQVPIFYTCNFTN,"EIAV (UK) Env",,,321,340,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",RKDYTGIYQVPIFYTCNFTN,"EIAV (UK) Env",321,340,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435969,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47900,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EIAV (UK) Env",,,331,350,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EIAV (UK) Env",331,350,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435970,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/29080,"Linear peptide",ITSCNNEPIISVIMYETNQV,"EIAV (UK) Env",,,341,360,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,8,66.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ITSCNNEPIISVIMYETNQV,"EIAV (UK) Env",341,360,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435971,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/62168,"Linear peptide",SVIMYETNQVQYLLCNNNNS,"EIAV (UK) Env",,,351,370,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",SVIMYETNQVQYLLCNNNNS,"EIAV (UK) Env",351,370,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435972,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/52993,"Linear peptide",QYLLCNNNNSNNYNCVVQSF,"EIAV (UK) Env",,,361,380,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",QYLLCNNNNSNNYNCVVQSF,"EIAV (UK) Env",361,380,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435973,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/45290,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EIAV (UK) Env",,,371,390,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EIAV (UK) Env",371,390,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435974,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/23001,"Linear peptide",GVIGQAHLELPRPNKRIRNQ,"EIAV (UK) Env",,,381,400,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",GVIGQAHLELPRPNKRIRNQ,"EIAV (UK) Env",381,400,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435975,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/49229,"Linear peptide",PRPNKRIRNQSFNQYNCSIN,"EIAV (UK) Env",,,391,410,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",PRPNKRIRNQSFNQYNCSIN,"EIAV (UK) Env",391,410,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435976,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/57858,"Linear peptide",SFNQYNCSINNKTELETWKL,"EIAV (UK) Env",,,401,420,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",SFNQYNCSINNKTELETWKL,"EIAV (UK) Env",401,420,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435977,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44604,"Linear peptide",NKTELETWKLVKTSGITPLP,"EIAV (UK) Env",,,411,430,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",NKTELETWKLVKTSGITPLP,"EIAV (UK) Env",411,430,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435978,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/69326,"Linear peptide",VKTSGITPLPISSEANTGLI,"EIAV (UK) Env",,,421,440,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",VKTSGITPLPISSEANTGLI,"EIAV (UK) Env",421,440,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435979,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/28711,"Linear peptide",ISSEANTGLIRHKRDFGISA,"EIAV (UK) Env",,,431,450,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ISSEANTGLIRHKRDFGISA,"EIAV (UK) Env",431,450,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435980,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/54061,"Linear peptide",RHKRDFGISAIVAAIVAATA,"EIAV (UK) Env",,,441,460,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",RHKRDFGISAIVAAIVAATA,"EIAV (UK) Env",441,460,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435981,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/29190,"Linear peptide",IVAAIVAATAIAASATMSYV,"EIAV (UK) Env",,,451,470,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",IVAAIVAATAIAASATMSYV,"EIAV (UK) Env",451,470,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435982,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/25234,"Linear peptide",IAASATMSYVALTEVNKIME,"EIAV (UK) Env",,,461,480,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",IAASATMSYVALTEVNKIME,"EIAV (UK) Env",461,480,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435983,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/2923,"Linear peptide",ALTEVNKIMEVQNHTFEVEN,"EIAV (UK) Env",,,471,490,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",ALTEVNKIMEVQNHTFEVEN,"EIAV (UK) Env",471,490,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435984,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/70617,"Linear peptide",VQNHTFEVENSTLNGMDLIE,"EIAV (UK) Env",,,481,500,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",VQNHTFEVENSTLNGMDLIE,"EIAV (UK) Env",481,500,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435985,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/61733,"Linear peptide",STLNGMDLIERQIKILYAMI,"EIAV (UK) Env",,,491,510,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",STLNGMDLIERQIKILYAMI,"EIAV (UK) Env",491,510,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435986,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/55427,"Linear peptide",RQIKILYAMILQTHADVQLL,"EIAV (UK) Env",,,501,520,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",RQIKILYAMILQTHADVQLL,"EIAV (UK) Env",501,520,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435987,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/38998,"Linear peptide",LQTHADVQLLKERQQVEETF,"EIAV (UK) Env",,,511,530,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",LQTHADVQLLKERQQVEETF,"EIAV (UK) Env",511,530,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435988,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/30593,"Linear peptide",KERQQVEETFNLIGCIERTH,"EIAV (UK) Env",,,521,540,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",KERQQVEETFNLIGCIERTH,"EIAV (UK) Env",521,540,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435989,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44743,"Linear peptide",NLIGCIERTHVFCHTGHPWN,"EIAV (UK) Env",,,531,550,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",NLIGCIERTHVFCHTGHPWN,"EIAV (UK) Env",531,550,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435990,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/68437,"Linear peptide",VFCHTGHPWNMSWGHLNEST,"EIAV (UK) Env",,,541,560,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",VFCHTGHPWNMSWGHLNEST,"EIAV (UK) Env",541,560,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435991,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/42715,"Linear peptide",MSWGHLNESTQWDDWVSKME,"EIAV (UK) Env",,,551,570,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",MSWGHLNESTQWDDWVSKME,"EIAV (UK) Env",551,570,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435992,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/52828,"Linear peptide",QWDDWVSKMEDLNQEILTIL,"EIAV (UK) Env",,,561,580,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",QWDDWVSKMEDLNQEILTIL,"EIAV (UK) Env",561,580,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435993,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/9224,"Linear peptide",DLNQEILTILHGARNNLAQS,"EIAV (UK) Env",,,571,590,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",DLNQEILTILHGARNNLAQS,"EIAV (UK) Env",571,590,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435994,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/23889,"Linear peptide",HGARNNLAQSMITFNTPDSI,"EIAV (UK) Env",,,581,600,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",HGARNNLAQSMITFNTPDSI,"EIAV (UK) Env",581,600,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435995,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/41781,"Linear peptide",MITFNTPDSIAQFGKDLWSH,"EIAV (UK) Env",,,591,610,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",MITFNTPDSIAQFGKDLWSH,"EIAV (UK) Env",591,610,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435996,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/3960,"Linear peptide",AQFGKDLWSHIGNWIPGLGA,"EIAV (UK) Env",,,601,620,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",AQFGKDLWSHIGNWIPGLGA,"EIAV (UK) Env",601,620,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435997,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/26290,"Linear peptide",IGNWIPGLGASIIKYIVMFL,"EIAV (UK) Env",,,611,630,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",IGNWIPGLGASIIKYIVMFL,"EIAV (UK) Env",611,630,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435998,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/58552,"Linear peptide",SIIKYIVMFLLIYLLLTSSP,"EIAV (UK) Env",,,621,640,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",SIIKYIVMFLLIYLLLTSSP,"EIAV (UK) Env",621,640,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1435999,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/36778,"Linear peptide",LIYLLLTSSPKILRALWKVT,"EIAV (UK) Env",,,631,650,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",LIYLLLTSSPKILRALWKVT,"EIAV (UK) Env",631,650,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436000,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/31332,"Linear peptide",KILRALWKVTSGAGSSGSRY,"EIAV (UK) Env",,,641,660,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",KILRALWKVTSGAGSSGSRY,"EIAV (UK) Env",641,660,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436001,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/57970,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,"EIAV (UK) Env",,,651,670,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,8,66.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,"EIAV (UK) Env",651,670,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436002,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/36913,"Linear peptide",LKKKFHHKHASREDTWDQAQ,"EIAV (UK) Env",,,661,680,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",LKKKFHHKHASREDTWDQAQ,"EIAV (UK) Env",661,680,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436003,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/60644,"Linear peptide",SREDTWDQAQHNIHLAGVTG,"EIAV (UK) Env",,,671,690,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,4,33.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",SREDTWDQAQHNIHLAGVTG,"EIAV (UK) Env",671,690,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436004,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/24378,"Linear peptide",HNIHLAGVTGGSGDKYYKQK,"EIAV (UK) Env",,,681,700,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",HNIHLAGVTGGSGDKYYKQK,"EIAV (UK) Env",681,700,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436005,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/22334,"Linear peptide",GSGDKYYKQKCSRNDWNGES,"EIAV (UK) Env",,,691,710,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",GSGDKYYKQKCSRNDWNGES,"EIAV (UK) Env",691,710,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436006,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/7076,"Linear peptide",CSRNDWNGESEEYNRRPKSW,"EIAV (UK) Env",,,701,720,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",CSRNDWNGESEEYNRRPKSW,"EIAV (UK) Env",701,720,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436007,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11938,"Linear peptide",EEYNRRPKSWVKSIEAFGES,"EIAV (UK) Env",,,711,730,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",EEYNRRPKSWVKSIEAFGES,"EIAV (UK) Env",711,730,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436008,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/69316,"Linear peptide",VKSIEAFGESYISEKTKGEI,"EIAV (UK) Env",,,721,740,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,3,25,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",VKSIEAFGESYISEKTKGEI,"EIAV (UK) Env",721,740,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436009,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/74370,"Linear peptide",YISEKTKGEISQPGAAINEH,"EIAV (UK) Env",,,731,750,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,4,33.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",YISEKTKGEISQPGAAINEH,"EIAV (UK) Env",731,750,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436010,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/60524,"Linear peptide",SQPGAAINEHKNGSGGNNPH,"EIAV (UK) Env",,,741,760,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",SQPGAAINEHKNGSGGNNPH,"EIAV (UK) Env",741,760,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436011,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/32504,"Linear peptide",KNGSGGNNPHQGSLDLEIRS,"EIAV (UK) Env",,,751,770,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,5,41.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KNGSGGNNPHQGSLDLEIRS,"EIAV (UK) Env",751,770,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436012,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/50958,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,"EIAV (UK) Env",,,761,780,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,"EIAV (UK) Env",761,780,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436013,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/12175,"Linear peptide",EGGNIYDCCIKAQEGTLAIP,"EIAV (UK) Env",,,771,790,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",EGGNIYDCCIKAQEGTLAIP,"EIAV (UK) Env",771,790,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436014,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/29919,"Linear peptide",KAQEGTLAIPCCGFPLWLFW,"EIAV (UK) Env",,,781,800,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",KAQEGTLAIPCCGFPLWLFW,"EIAV (UK) Env",781,800,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436015,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/6062,"Linear peptide",CCGFPLWLFWGLVIIVGRIA,"EIAV (UK) Env",,,791,810,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",CCGFPLWLFWGLVIIVGRIA,"EIAV (UK) Env",791,810,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436016,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/21197,"Linear peptide",GLVIIVGRIAGYGLRGLAVI,"EIAV (UK) Env",,,801,820,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,3,25,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",GLVIIVGRIAGYGLRGLAVI,"EIAV (UK) Env",801,820,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436017,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/23343,"Linear peptide",GYGLRGLAVIIRICIRGLNL,"EIAV (UK) Env",,,811,830,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",GYGLRGLAVIIRICIRGLNL,"EIAV (UK) Env",811,830,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436018,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/28316,"Linear peptide",IRICIRGLNLIFEIIRKMLD,"EIAV (UK) Env",,,821,840,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,7,58.3,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",IRICIRGLNLIFEIIRKMLD,"EIAV (UK) Env",821,840,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436019,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/26054,"Linear peptide",IFEIIRKMLDYIGRALNPGT,"EIAV (UK) Env",,,831,850,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",IFEIIRKMLDYIGRALNPGT,"EIAV (UK) Env",831,850,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436020,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/74221,"Linear peptide",YIGRALNPGTSHVSMPQYV,"EIAV (UK) Env",,,841,859,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 2",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope. No response was observed to this peptide.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD4+",http://purl.obolibrary.org/obo/CL_0000624,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",YIGRALNPGTSHVSMPQYV,"EIAV (UK) Env",841,859,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436043,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/42993,"Linear peptide",MVSIAFYGGIPGGISTPITQ,"EIAV (UK) Env",,,1,20,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",MVSIAFYGGIPGGISTPITQ,"EIAV (UK) Env",1,20,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436050,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47665,"Linear peptide",PGGISTPITQQSEKSKCEEN,"EIAV (UK) Env",,,11,30,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PGGISTPITQQSEKSKCEEN,"EIAV (UK) Env",11,30,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436051,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/52310,"Linear peptide",QSEKSKCEENTMFQPYCYNN,"EIAV (UK) Env",,,21,40,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",QSEKSKCEENTMFQPYCYNN,"EIAV (UK) Env",21,40,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436052,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/65201,"Linear peptide",TMFQPYCYNNDSKNSMAESK,"EIAV (UK) Env",,,31,50,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",TMFQPYCYNNDSKNSMAESK,"EIAV (UK) Env",31,50,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436053,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/10156,"Linear peptide",DSKNSMAESKEARDQEMNLK,"EIAV (UK) Env",,,41,60,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,6,50,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DSKNSMAESKEARDQEMNLK,"EIAV (UK) Env",41,60,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436054,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11179,"Linear peptide",EARDQEMNLKEESKEEKRRN,"EIAV (UK) Env",,,51,70,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EARDQEMNLKEESKEEKRRN,"EIAV (UK) Env",51,70,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436055,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11878,"Linear peptide",EESKEEKRRNDWWKIGMFLL,"EIAV (UK) Env",,,61,80,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EESKEEKRRNDWWKIGMFLL,"EIAV (UK) Env",61,80,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436056,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/10836,"Linear peptide",DWWKIGMFLLCLAGTTGGIL,"EIAV (UK) Env",,,71,90,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DWWKIGMFLLCLAGTTGGIL,"EIAV (UK) Env",71,90,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436057,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/6537,"Linear peptide",CLAGTTGGILWWYEGLPQQH,"EIAV (UK) Env",,,81,100,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,8,66.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",CLAGTTGGILWWYEGLPQQH,"EIAV (UK) Env",81,100,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436058,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/73255,"Linear peptide",WWYEGLPQQHYIGLVAIGGR,"EIAV (UK) Env",,,91,110,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",WWYEGLPQQHYIGLVAIGGR,"EIAV (UK) Env",91,110,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436060,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/74218,"Linear peptide",YIGLVAIGGRLNGSGQSNAI,"EIAV (UK) Env",,,101,120,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",YIGLVAIGGRLNGSGQSNAI,"EIAV (UK) Env",101,120,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436061,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/38223,"Linear peptide",LNGSGQSNAIECWGSFPGCR,"EIAV (UK) Env",,,111,130,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LNGSGQSNAIECWGSFPGCR,"EIAV (UK) Env",111,130,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436062,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11274,"Linear peptide",ECWGSFPGCRPFQNYFSYET,"EIAV (UK) Env",,,121,140,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ECWGSFPGCRPFQNYFSYET,"EIAV (UK) Env",121,140,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436063,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47555,"Linear peptide",PFQNYFSYETNRSMHMDNNT,"EIAV (UK) Env",,,131,150,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PFQNYFSYETNRSMHMDNNT,"EIAV (UK) Env",131,150,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436064,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/45737,"Linear peptide",NRSMHMDNNTATLLEAYHRE,"EIAV (UK) Env",,,141,160,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NRSMHMDNNTATLLEAYHRE,"EIAV (UK) Env",141,160,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436065,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/5037,"Linear peptide",ATLLEAYHREITFIYKSSCT,"EIAV (UK) Env",,,151,170,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ATLLEAYHREITFIYKSSCT,"EIAV (UK) Env",151,170,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436066,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/28895,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,"EIAV (UK) Env",,,161,180,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,6,50,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,"EIAV (UK) Env",161,180,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436067,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/10092,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,"EIAV (UK) Env",,,171,190,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,"EIAV (UK) Env",171,190,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436068,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/31731,"Linear peptide",KKVNLNSSDSSNPVRVEDVM,"EIAV (UK) Env",,,181,200,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KKVNLNSSDSSNPVRVEDVM,"EIAV (UK) Env",181,200,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436069,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/59882,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EIAV (UK) Env",,,191,210,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EIAV (UK) Env",191,210,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436070,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/46279,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EIAV (UK) Env",,,201,220,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,4,33.3,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EIAV (UK) Env",201,220,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436071,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/35372,"Linear peptide",LECNQTENFKTILVPENEMV,"EIAV (UK) Env",,,211,230,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LECNQTENFKTILVPENEMV,"EIAV (UK) Env",211,230,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436072,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/64372,"Linear peptide",TILVPENEMVNINDTDTWIP,"EIAV (UK) Env",,,221,240,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,5,41.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",TILVPENEMVNINDTDTWIP,"EIAV (UK) Env",221,240,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436073,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44295,"Linear peptide",NINDTDTWIPKGCNETWARV,"EIAV (UK) Env",,,231,250,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NINDTDTWIPKGCNETWARV,"EIAV (UK) Env",231,250,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436074,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/30904,"Linear peptide",KGCNETWARVKRCPIDILYG,"EIAV (UK) Env",,,241,260,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KGCNETWARVKRCPIDILYG,"EIAV (UK) Env",241,260,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436075,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/33114,"Linear peptide",KRCPIDILYGIHPIRLCVQP,"EIAV (UK) Env",,,251,270,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KRCPIDILYGIHPIRLCVQP,"EIAV (UK) Env",251,270,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436076,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/26399,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EIAV (UK) Env",,,261,280,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,6,50,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EIAV (UK) Env",261,280,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436077,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47490,"Linear peptide",PFFLVQEKGIANTSRIGNCG,"EIAV (UK) Env",,,271,290,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,4,33.3,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PFFLVQEKGIANTSRIGNCG,"EIAV (UK) Env",271,290,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436078,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/3430,"Linear peptide",ANTSRIGNCGPTIFLGVLED,"EIAV (UK) Env",,,281,300,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ANTSRIGNCGPTIFLGVLED,"EIAV (UK) Env",281,300,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436079,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/49664,"Linear peptide",PTIFLGVLEDNKGVVRGNYT,"EIAV (UK) Env",,,291,310,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PTIFLGVLEDNKGVVRGNYT,"EIAV (UK) Env",291,310,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436080,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44499,"Linear peptide",NKGVVRGNYTACNVSRLKIN,"EIAV (UK) Env",,,301,320,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NKGVVRGNYTACNVSRLKIN,"EIAV (UK) Env",301,320,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436081,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/583,"Linear peptide",ACNVSRLKINRKDYTGIYQV,"EIAV (UK) Env",,,311,330,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ACNVSRLKINRKDYTGIYQV,"EIAV (UK) Env",311,330,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436082,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/54336,"Linear peptide",RKDYTGIYQVPIFYTCNFTN,"EIAV (UK) Env",,,321,340,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RKDYTGIYQVPIFYTCNFTN,"EIAV (UK) Env",321,340,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436083,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/47900,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EIAV (UK) Env",,,331,350,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EIAV (UK) Env",331,350,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436084,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/29080,"Linear peptide",ITSCNNEPIISVIMYETNQV,"EIAV (UK) Env",,,341,360,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,1,8.3,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ITSCNNEPIISVIMYETNQV,"EIAV (UK) Env",341,360,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436085,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/62168,"Linear peptide",SVIMYETNQVQYLLCNNNNS,"EIAV (UK) Env",,,351,370,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SVIMYETNQVQYLLCNNNNS,"EIAV (UK) Env",351,370,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436086,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/52993,"Linear peptide",QYLLCNNNNSNNYNCVVQSF,"EIAV (UK) Env",,,361,380,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",QYLLCNNNNSNNYNCVVQSF,"EIAV (UK) Env",361,380,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436087,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/45290,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EIAV (UK) Env",,,371,390,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EIAV (UK) Env",371,390,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436088,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/23001,"Linear peptide",GVIGQAHLELPRPNKRIRNQ,"EIAV (UK) Env",,,381,400,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",GVIGQAHLELPRPNKRIRNQ,"EIAV (UK) Env",381,400,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436089,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/49229,"Linear peptide",PRPNKRIRNQSFNQYNCSIN,"EIAV (UK) Env",,,391,410,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PRPNKRIRNQSFNQYNCSIN,"EIAV (UK) Env",391,410,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436090,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/57858,"Linear peptide",SFNQYNCSINNKTELETWKL,"EIAV (UK) Env",,,401,420,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SFNQYNCSINNKTELETWKL,"EIAV (UK) Env",401,420,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436091,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44604,"Linear peptide",NKTELETWKLVKTSGITPLP,"EIAV (UK) Env",,,411,430,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NKTELETWKLVKTSGITPLP,"EIAV (UK) Env",411,430,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436092,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/69326,"Linear peptide",VKTSGITPLPISSEANTGLI,"EIAV (UK) Env",,,421,440,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",VKTSGITPLPISSEANTGLI,"EIAV (UK) Env",421,440,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436093,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/28711,"Linear peptide",ISSEANTGLIRHKRDFGISA,"EIAV (UK) Env",,,431,450,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ISSEANTGLIRHKRDFGISA,"EIAV (UK) Env",431,450,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436094,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/54061,"Linear peptide",RHKRDFGISAIVAAIVAATA,"EIAV (UK) Env",,,441,460,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,1,8.3,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RHKRDFGISAIVAAIVAATA,"EIAV (UK) Env",441,460,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436095,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/29190,"Linear peptide",IVAAIVAATAIAASATMSYV,"EIAV (UK) Env",,,451,470,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IVAAIVAATAIAASATMSYV,"EIAV (UK) Env",451,470,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436096,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/25234,"Linear peptide",IAASATMSYVALTEVNKIME,"EIAV (UK) Env",,,461,480,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IAASATMSYVALTEVNKIME,"EIAV (UK) Env",461,480,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436097,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/2923,"Linear peptide",ALTEVNKIMEVQNHTFEVEN,"EIAV (UK) Env",,,471,490,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ALTEVNKIMEVQNHTFEVEN,"EIAV (UK) Env",471,490,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436098,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/70617,"Linear peptide",VQNHTFEVENSTLNGMDLIE,"EIAV (UK) Env",,,481,500,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",VQNHTFEVENSTLNGMDLIE,"EIAV (UK) Env",481,500,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436099,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/61733,"Linear peptide",STLNGMDLIERQIKILYAMI,"EIAV (UK) Env",,,491,510,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,6,50,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",STLNGMDLIERQIKILYAMI,"EIAV (UK) Env",491,510,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436100,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/55427,"Linear peptide",RQIKILYAMILQTHADVQLL,"EIAV (UK) Env",,,501,520,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RQIKILYAMILQTHADVQLL,"EIAV (UK) Env",501,520,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436101,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/38998,"Linear peptide",LQTHADVQLLKERQQVEETF,"EIAV (UK) Env",,,511,530,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,5,41.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LQTHADVQLLKERQQVEETF,"EIAV (UK) Env",511,530,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436102,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/30593,"Linear peptide",KERQQVEETFNLIGCIERTH,"EIAV (UK) Env",,,521,540,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,1,8.3,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KERQQVEETFNLIGCIERTH,"EIAV (UK) Env",521,540,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436103,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/44743,"Linear peptide",NLIGCIERTHVFCHTGHPWN,"EIAV (UK) Env",,,531,550,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NLIGCIERTHVFCHTGHPWN,"EIAV (UK) Env",531,550,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436104,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/68437,"Linear peptide",VFCHTGHPWNMSWGHLNEST,"EIAV (UK) Env",,,541,560,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",VFCHTGHPWNMSWGHLNEST,"EIAV (UK) Env",541,560,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436105,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/42715,"Linear peptide",MSWGHLNESTQWDDWVSKME,"EIAV (UK) Env",,,551,570,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",MSWGHLNESTQWDDWVSKME,"EIAV (UK) Env",551,570,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436106,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/52828,"Linear peptide",QWDDWVSKMEDLNQEILTIL,"EIAV (UK) Env",,,561,580,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",QWDDWVSKMEDLNQEILTIL,"EIAV (UK) Env",561,580,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436107,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/9224,"Linear peptide",DLNQEILTILHGARNNLAQS,"EIAV (UK) Env",,,571,590,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DLNQEILTILHGARNNLAQS,"EIAV (UK) Env",571,590,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436108,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/23889,"Linear peptide",HGARNNLAQSMITFNTPDSI,"EIAV (UK) Env",,,581,600,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",HGARNNLAQSMITFNTPDSI,"EIAV (UK) Env",581,600,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436109,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/41781,"Linear peptide",MITFNTPDSIAQFGKDLWSH,"EIAV (UK) Env",,,591,610,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",MITFNTPDSIAQFGKDLWSH,"EIAV (UK) Env",591,610,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436112,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/3960,"Linear peptide",AQFGKDLWSHIGNWIPGLGA,"EIAV (UK) Env",,,601,620,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",AQFGKDLWSHIGNWIPGLGA,"EIAV (UK) Env",601,620,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436113,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/26290,"Linear peptide",IGNWIPGLGASIIKYIVMFL,"EIAV (UK) Env",,,611,630,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IGNWIPGLGASIIKYIVMFL,"EIAV (UK) Env",611,630,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436114,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/58552,"Linear peptide",SIIKYIVMFLLIYLLLTSSP,"EIAV (UK) Env",,,621,640,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SIIKYIVMFLLIYLLLTSSP,"EIAV (UK) Env",621,640,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436115,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/36778,"Linear peptide",LIYLLLTSSPKILRALWKVT,"EIAV (UK) Env",,,631,650,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LIYLLLTSSPKILRALWKVT,"EIAV (UK) Env",631,650,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436116,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/31332,"Linear peptide",KILRALWKVTSGAGSSGSRY,"EIAV (UK) Env",,,641,660,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KILRALWKVTSGAGSSGSRY,"EIAV (UK) Env",641,660,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436117,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/57970,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,"EIAV (UK) Env",,,651,670,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,"EIAV (UK) Env",651,670,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436118,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/36913,"Linear peptide",LKKKFHHKHASREDTWDQAQ,"EIAV (UK) Env",,,661,680,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LKKKFHHKHASREDTWDQAQ,"EIAV (UK) Env",661,680,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436119,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/60644,"Linear peptide",SREDTWDQAQHNIHLAGVTG,"EIAV (UK) Env",,,671,690,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,3,25,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SREDTWDQAQHNIHLAGVTG,"EIAV (UK) Env",671,690,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436120,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/24378,"Linear peptide",HNIHLAGVTGGSGDKYYKQK,"EIAV (UK) Env",,,681,700,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",HNIHLAGVTGGSGDKYYKQK,"EIAV (UK) Env",681,700,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436121,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/22334,"Linear peptide",GSGDKYYKQKCSRNDWNGES,"EIAV (UK) Env",,,691,710,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",GSGDKYYKQKCSRNDWNGES,"EIAV (UK) Env",691,710,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436122,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/7076,"Linear peptide",CSRNDWNGESEEYNRRPKSW,"EIAV (UK) Env",,,701,720,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",CSRNDWNGESEEYNRRPKSW,"EIAV (UK) Env",701,720,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436123,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11938,"Linear peptide",EEYNRRPKSWVKSIEAFGES,"EIAV (UK) Env",,,711,730,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EEYNRRPKSWVKSIEAFGES,"EIAV (UK) Env",711,730,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436124,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/69316,"Linear peptide",VKSIEAFGESYISEKTKGEI,"EIAV (UK) Env",,,721,740,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",VKSIEAFGESYISEKTKGEI,"EIAV (UK) Env",721,740,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436125,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/74370,"Linear peptide",YISEKTKGEISQPGAAINEH,"EIAV (UK) Env",,,731,750,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",YISEKTKGEISQPGAAINEH,"EIAV (UK) Env",731,750,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436126,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/60524,"Linear peptide",SQPGAAINEHKNGSGGNNPH,"EIAV (UK) Env",,,741,760,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SQPGAAINEHKNGSGGNNPH,"EIAV (UK) Env",741,760,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436127,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/32504,"Linear peptide",KNGSGGNNPHQGSLDLEIRS,"EIAV (UK) Env",,,751,770,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,2,16.7,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KNGSGGNNPHQGSLDLEIRS,"EIAV (UK) Env",751,770,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436128,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/50958,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,"EIAV (UK) Env",,,761,780,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,"EIAV (UK) Env",761,780,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436129,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/12175,"Linear peptide",EGGNIYDCCIKAQEGTLAIP,"EIAV (UK) Env",,,771,790,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EGGNIYDCCIKAQEGTLAIP,"EIAV (UK) Env",771,790,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436130,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/29919,"Linear peptide",KAQEGTLAIPCCGFPLWLFW,"EIAV (UK) Env",,,781,800,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KAQEGTLAIPCCGFPLWLFW,"EIAV (UK) Env",781,800,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436131,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/6062,"Linear peptide",CCGFPLWLFWGLVIIVGRIA,"EIAV (UK) Env",,,791,810,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",CCGFPLWLFWGLVIIVGRIA,"EIAV (UK) Env",791,810,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436132,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/21197,"Linear peptide",GLVIIVGRIAGYGLRGLAVI,"EIAV (UK) Env",,,801,820,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",GLVIIVGRIAGYGLRGLAVI,"EIAV (UK) Env",801,820,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436133,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/23343,"Linear peptide",GYGLRGLAVIIRICIRGLNL,"EIAV (UK) Env",,,811,830,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",GYGLRGLAVIIRICIRGLNL,"EIAV (UK) Env",811,830,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436134,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/28316,"Linear peptide",IRICIRGLNLIFEIIRKMLD,"EIAV (UK) Env",,,821,840,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IRICIRGLNLIFEIIRKMLD,"EIAV (UK) Env",821,840,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436135,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/26054,"Linear peptide",IFEIIRKMLDYIGRALNPGT,"EIAV (UK) Env",,,831,850,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IFEIIRKMLDYIGRALNPGT,"EIAV (UK) Env",831,850,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1436136,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/74221,"Linear peptide",YIGRALNPGTSHVSMPQYV,"EIAV (UK) Env",,,841,859,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock. PBMCs were expanded in vitro for 7-10 days with purified EIAV (10ug/ml) prior to CTL assay.","Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,12,0,0,"PBMCs from 12 vaccinated horses were tested for cytolysis against peptide-pulsed targets.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",YIGRALNPGTSHVSMPQYV,"EIAV (UK) Env",841,859,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1459545,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/11878,"Linear peptide",EESKEEKRRNDWWKIGMFLL,"EIAV (UK) Env",,,61,80,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,8,66.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  This peptide elicited both CD4 and CD8 proliferation. All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,I,Epitope,"Linear peptide",EESKEEKRRNDWWKIGMFLL,"EIAV (UK) Env",61,80,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1459546,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/57970,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,"EIAV (UK) Env",,,651,670,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,11,91.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  This peptide elicited both CD4 and CD8 proliferation. All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,I,Epitope,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,"EIAV (UK) Env",651,670,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1459547,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/60644,"Linear peptide",SREDTWDQAQHNIHLAGVTG,"EIAV (UK) Env",,,671,690,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,8,66.7,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  This peptide elicited both CD4 and CD8 proliferation. All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,I,Epitope,"Linear peptide",SREDTWDQAQHNIHLAGVTG,"EIAV (UK) Env",671,690,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1459549,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/50958,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,"EIAV (UK) Env",,,761,780,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,9,75,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  This peptide elicited both CD4 and CD8 proliferation. All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,I,Epitope,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,"EIAV (UK) Env",761,780,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1459550,http://www.iedb.org/reference/1006269,Literature,17374779,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Charles J Issel; Ronald C Montelaro","J Gen Virol",2007,"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.",http://www.iedb.org/epitope/41781,"Linear peptide",MITFNTPDSIAQFGKDLWSH,"EIAV (UK) Env",,,591,610,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus D9","Live-attenuated EIAV (D9) vaccine",,,,,,,,"Equine infectious anemia virus D9",https://ontology.iedb.org/taxon/10000498,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intramuscular,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Twelve horses were vaccinated with live-attenuated EIAV (D9), which contains an engineered 9 base pair deletion and 2 termination codons in the viral S2 gene. Each vaccinated horse seroconverted by 35 days post-inoculation and responses were confirmed at 6 months post-vaccination. Horses were vaccinated twice at 30-day intervals by injection of 105 50% tissue culture infective dose (TCID50) of the vaccine stock.","Figure 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,9,75,"PBMCs from 12 vaccinated horses were tested for proliferation in response to the epitope.  This peptide elicited both CD4 and CD8 proliferation. All 12 horses were protected from virulent virus challenge, as evidenced by lack of clinical signs and undetectable virus in plasma.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,I,Epitope,"Linear peptide",MITFNTPDSIAQFGKDLWSH,"EIAV (UK) Env",591,610,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1462578,http://www.iedb.org/reference/1006567,Literature,16105689,,"A Soutullo; M I García; A Bailat; A Racca; G Tonarelli; I Malan Borel","Vet Immunol Immunopathol",2005,"Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.",http://www.iedb.org/epitope/14061,"Linear peptide",ERQQVEETFNLIGCIERTHVFCHTG,"gp45 peptide",,,522,546,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Equine infectious anemia virus",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",BrdU,proliferation,,http://purl.obolibrary.org/obo/OBI_1110181,Positive,,,5,3,60,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ERQQVEETFNLIGCIERTHVFCHTG,"gp45 peptide",522,546,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1462579,http://www.iedb.org/reference/1006567,Literature,16105689,,"A Soutullo; M I García; A Bailat; A Racca; G Tonarelli; I Malan Borel","Vet Immunol Immunopathol",2005,"Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.",http://www.iedb.org/epitope/3249,"Linear peptide",ANEECRNAMRHLRPEDTLEEKMYACRDIG,"p26 peptide",,,318,346,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Exposure with existing immune reactivity without evidence for disease",healthy,https://ontology.iedb.org/ontology/ONTIE_0003423,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Equine infectious anemia virus",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2",BrdU,proliferation,,http://purl.obolibrary.org/obo/OBI_1110181,Positive,,,5,3,60,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ANEECRNAMRHLRPEDTLEEKMYACRDIG,"p26 peptide",318,346,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1462580,http://www.iedb.org/reference/1006567,Literature,16105689,,"A Soutullo; M I García; A Bailat; A Racca; G Tonarelli; I Malan Borel","Vet Immunol Immunopathol",2005,"Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.",http://www.iedb.org/epitope/14061,"Linear peptide",ERQQVEETFNLIGCIERTHVFCHTG,"gp45 peptide",,,522,546,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"3 months",,"Administration in vivo",,,,Epitope,"Linear peptide",ERQQVEETFNLIGCIERTHVFCHTG,"gp45 peptide",522,546,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;",subcutaneous,"6 doses of 100 micrograms of epitope peptide, administered at intervals of 15 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4",BrdU,proliferation,,http://purl.obolibrary.org/obo/OBI_1110181,Positive,,,,,,"In a parallel assay, mice immunized with 20 micrograms of epitopic peptide generated a very similar proliferative response as mice immunized with 100 micrograms.",Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo","H2-d class II",http://purl.obolibrary.org/obo/MRO_0001774,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ERQQVEETFNLIGCIERTHVFCHTG,"gp45 peptide",522,546,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1462581,http://www.iedb.org/reference/1006567,Literature,16105689,,"A Soutullo; M I García; A Bailat; A Racca; G Tonarelli; I Malan Borel","Vet Immunol Immunopathol",2005,"Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.",http://www.iedb.org/epitope/3249,"Linear peptide",ANEECRNAMRHLRPEDTLEEKMYACRDIG,"p26 peptide",,,318,346,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Mus musculus BALB/c",https://ontology.iedb.org/ontology/ONTIE_0000001,,,F,"3 months",,"Administration in vivo",,,,Epitope,"Linear peptide",ANEECRNAMRHLRPEDTLEEKMYACRDIG,"p26 peptide",318,346,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;",subcutaneous,"6 doses of 100 micrograms of epitope peptide, administered at intervals of 15 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4",BrdU,proliferation,,http://purl.obolibrary.org/obo/OBI_1110181,Positive,,,,,,"In a parallel assay, mice immunized with 20 micrograms of epitopic peptide generated a very similar proliferative response as mice immunized with 100 micrograms.",Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo","H2-d class II",http://purl.obolibrary.org/obo/MRO_0001774,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ANEECRNAMRHLRPEDTLEEKMYACRDIG,"p26 peptide",318,346,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1467493,http://www.iedb.org/reference/1006215,Literature,7543872,,"J N Flynn; C A Cannon; G Reid; M A Rigby; J C Neil; O Jarrett",Immunology,1995,"Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.",http://www.iedb.org/epitope/53121,"Linear peptide",RAISSWKQRN,"env peptide 1",,,389,398,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,"12 weeks-old",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",RAISSWKQRNRWEWRPD,"env protein aa 390-406",389,405,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,";Alum (Aluminum hydroxide gel);",subcutaneous,"3 injections at 3 week intervals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were immunized with the peptide as an eight-branched poly-lysine core with Quil A and adjuvant in PBS.","Figure 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,10,3,30,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class I",http://purl.obolibrary.org/obo/MRO_0001460,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RAISSWKQRN,"env peptide 1",389,398,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/1467496,http://www.iedb.org/reference/1006215,Literature,7543872,,"J N Flynn; C A Cannon; G Reid; M A Rigby; J C Neil; O Jarrett",Immunology,1995,"Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.",http://www.iedb.org/epitope/62470,"Linear peptide",SWKQRNRWEW,"env peptide 2",,,393,402,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,"12 weeks-old",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",RAISSWKQRNRWEWRPD,"env protein aa 390-406",389,405,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,";Alum (Aluminum hydroxide gel);",subcutaneous,"3 injections at 3 week intervals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were immunized with the peptide as an eight-branched poly-lysine core with Quil A and adjuvant in PBS.","Figure 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,10,3,30,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class I",http://purl.obolibrary.org/obo/MRO_0001460,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SWKQRNRWEW,"env peptide 2",393,402,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/1467498,http://www.iedb.org/reference/1006215,Literature,7543872,,"J N Flynn; C A Cannon; G Reid; M A Rigby; J C Neil; O Jarrett",Immunology,1995,"Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.",http://www.iedb.org/epitope/52238,"Linear peptide",QRNRWEWRPD,"env peptide 3",,,396,405,,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,"12 weeks-old",,"Administration in vivo",,,,"Fragment of Source Antigen","Linear peptide",RAISSWKQRNRWEWRPD,"env protein aa 390-406",389,405,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,";Alum (Aluminum hydroxide gel);",subcutaneous,"3 injections at 3 week intervals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were immunized with the peptide as an eight-branched poly-lysine core with Quil A and adjuvant in PBS.","Figure 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,10,1,10,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class I",http://purl.obolibrary.org/obo/MRO_0001460,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",QRNRWEWRPD,"env peptide 3",396,405,,"Envelope glycoprotein gp150",http://www.ncbi.nlm.nih.gov/protein/P16090.2,"Envelope glycoprotein gp150",http://www.uniprot.org/uniprot/P16090,"Feline immunodeficiency virus (isolate Petaluma)",http://purl.obolibrary.org/obo/NCBITaxon_11674,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/1469960,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,Env195-206RW12,,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1 and Figures 6, 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope was recognized by CTL from a horse that had progressive EIAV. A functional avidity of 0.21 nM was determined. An analysis of variants that appeared during recurrent viremic episodes suggests that R195, E197, V199, and A203 are important residues for recognition of this epitope.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",RVEDVTNTAEYW,Env195-206RW12,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470323,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,Gag21-32GW12,,,47,58,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The p15 portion of Gag referenced in the paper lies within the larger PR55gag region identified in the database source and the numbering of the amino acids therefore differs.",,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GSQKLTTGNCNW,,47,58,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1 and Figures 6, 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope was recognized by CTL from a horse that had progressive EIAV. A functional avidity of 155 nM was determined.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",GSQKLTTGNCNW,Gag21-32GW12,47,58,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470324,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/18137,"Linear peptide",FVDRLLSQIK,Gag288-297FK10,,,314,323,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The p26 portion of Gag referenced in the paper lies within a larger PR55gag region identified in the database source and the numbering of the amino acids therefore differs.",,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",FVDRLLSQIK,,314,323,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1 and Figures 6, 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope was recognized by CTL from a horse that had progressive EIAV. A functional avidity of 18.7 nM was determined.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",FVDRLLSQIK,Gag288-297FK10,314,323,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470325,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/50248,"Linear peptide",QAEVLQERLEW,Rev57-67QW11,,,57,67,,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",QAEVLQERLEW,,57,67,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1 and Figures 6, 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope was recognized by CTL from a horse with a non-progressive response to EIAV infection. A functional avidity of 0.29 nM was determined.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",QAEVLQERLEW,Rev57-67QW11,57,67,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470326,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/49269,"Linear peptide",PRVLRPGDSKRR,Rev120-131PR12,,,120,131,,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",PRVLRPGDSKRR,,120,131,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1 and Figures 6, 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope was recognized by CTL from a horse with a non-progressive response to EIAV infection. A functional avidity of 5658 nM was determined.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",PRVLRPGDSKRR,Rev120-131PR12,120,131,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470327,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/28069,"Linear peptide",IPSQTCITRR,Rev24-33IR10,,,24,33,,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year","ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IPSQTCITRR,,24,33,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Tables 1, 2 and Figures 6, 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope was recognized by CTL from a horse with a non-progressive response to EIAV infection. A functional avidity of 47.8 nM was determined.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",IPSQTCITRR,Rev24-33IR10,24,33,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470328,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/20106,"Linear peptide",GGYQRAQER,Rev104-112GR9,,,104,112,,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year","ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GGYQRAQER,,104,112,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Tables 1, 2 and Figures 6, 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope was recognized by CTL from a horse with a non-progressive response to EIAV infection. A functional avidity of 25.1 nM was determined.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",GGYQRAQER,Rev104-112GR9,104,112,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470366,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/25056,"Linear peptide",HVKDETNTTEYW,Env195-206HW12v,,,72,83,,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAP34871.1,"Envelope protein (Fragment)",http://www.uniprot.org/uniprot/Q7SW18,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"This epitope is from a variant isolated from a horse infected with strain WSU5 that developed progressive EIAV. Only a small portion of the envelope protein was sequenced and submitted to the database, so the amino acid sequences from the fragment differ from the envelope protein described in the paper.",,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",HVKDETNTTEYW,,72,83,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAP34871.1,"Envelope protein (Fragment)",http://www.uniprot.org/uniprot/Q7SW18,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1 and Figure 3a-d","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,,,,"This epitope is a variant of EIAV envelope protein, aa 195-206 (RVEDVTNTAEYW), where the individual amino acid changes appeared either individually or all together in multiple isolates. The variant was isolated from a horse that had progressive EIAV, and is not recognized by CTL from that horse.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",HVKDETNTTEYW,Env195-206HW12v,72,83,,"envelope protein",http://www.ncbi.nlm.nih.gov/protein/AAP34871.1,"Envelope protein (Fragment)",http://www.uniprot.org/uniprot/Q7SW18,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470369,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/22466,"Linear peptide",GSQKLSTGNCNW,"Gag21-32 variant T26S",,,24,35,,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAP34920.1,"Gag protein (Fragment)",http://www.uniprot.org/uniprot/Q7SVW1,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"This epitope is from a variant isolated from a horse infected with strain WSU5 that developed progressive EIAV. The p15 portion of Gag referenced in the paper lies within a larger PR55gag region, of which a small portion was sequenced and submitted to the database from this EIAV variant, so that the numbering of the aa sequences does not correspond.",,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GSQKLSTGNCNW,,24,35,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAP34920.1,"Gag protein (Fragment)",http://www.uniprot.org/uniprot/Q7SVW1,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1, 2, Figure 3e","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope is a variant of EIAV p15 gag protein, aa 21-32 (GSQKLTTGNCNW), where the amino acid change T26S appeared in multiple isolates from a horse that had progressive EIAV. This epitope was, however, well recognized by CTL from that horse.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",GSQKLSTGNCNW,"Gag21-32 variant T26S",24,35,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAP34920.1,"Gag protein (Fragment)",http://www.uniprot.org/uniprot/Q7SVW1,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1470370,http://www.iedb.org/reference/1006471,Literature,12954220,,"Robert H Mealey; Baoshan Zhang; Steven R Leib; Matt H Littke; Travis C McGuire",Virology,2003,"Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.",http://www.iedb.org/epitope/22465,"Linear peptide",GSQKLNTGNCNW,"Gag21-32 variant T26N",,,24,35,,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAP34929.1,"Gag protein (Fragment)",http://www.uniprot.org/uniprot/Q7SVV2,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"This epitope is from a variant isolated from a horse infected with strain WSU5 that developed progressive EIAV. The p15 portion of Gag referenced in the paper lies within a larger PR55gag region, of which a small portion was sequenced and submitted to the database from this EIAV variant, so that the numbering of the aa sequences does not correspond.",,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"1 year",,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)","Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 107 50% tissue culture infective doses",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GSQKLNTGNCNW,,24,35,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAP34929.1,"Gag protein (Fragment)",http://www.uniprot.org/uniprot/Q7SVV2,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC were incubated with 40 μM peptide for 2 hours, after which excess peptide was removed and cells were cultured for seven days prior to use.","Table 1, 2, Figure 3e","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"This epitope is a variant of EIAV p15 gag protein, aa 21-32 (GSQKLTTGNCNW), where the amino acid change T26N appeared in multiple isolates from a horse that had progressive EIAV. This epitope was, however, well recognized by CTL from that horse.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",GSQKLNTGNCNW,"Gag21-32 variant T26N",24,35,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAP34929.1,"Gag protein (Fragment)",http://www.uniprot.org/uniprot/Q7SVV2,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474094,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"EIAV gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"EIAV gag (221-245)",221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYWRVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. The carrier was composed of Palmitic Acid. ","Table 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,5,5,100,"Highest number of responders was observed 1 week after viral challenge. Positive response was also observed in most horses one week after completion of the immunization.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"EIAV gag (221-245)",221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474095,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/55500,"Linear peptide",RQTYRQWIIEAMSEGIKVMI,"EIAV gag (250-269)",,,250,269,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",RQTYRQWIIEAMSEGIKVMI,"EIAV gag (250-269)",250,269,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYWRVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. The carrier was composed of Palmitic Acid. ","Table 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,5,5,100,"Highest number of responders was observed 1 week after viral challenge. Positive response was also observed in most horses one week after completion of the immunization.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",RQTYRQWIIEAMSEGIKVMI,"EIAV gag (250-269)",250,269,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474096,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/31824,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"EIAV gag (13-32)",,,13,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"EIAV gag (13-32)",13,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYWRVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. The carrier was composed of Palmitic Acid. ","Table 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,5,5,100,"Highest number of responders was observed 1 week after viral challenge. Positive response was also observed in most horses one week after completion of the immunization.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"EIAV gag (13-32)",13,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474097,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/38646,"Linear peptide",LPQGFVLSPYIYQKTLQEILQP,"EIAV pol (326-347)",,,334,355,,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P11204.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",LPQGFVLSPYIYQKTLQEILQP,"EIAV pol (326-347)",334,355,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P11204.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYWRVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. The carrier was composed of Palmitic Acid. ","Table 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,5,5,100,"Highest number of responders was observed 1 week after viral challenge. Positive response was also observed in most horses one week after completion of the immunization.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",LPQGFVLSPYIYQKTLQEILQP,"EIAV pol (326-347)",334,355,,"Pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/P11204.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474098,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/12612,"Linear peptide",EIVYFAWVPGHKGIYG,"EIAV pol (704-719)",,,704,719,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/NP_056902.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P11204,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",EIVYFAWVPGHKGIYG,"EIAV pol (704-719)",704,719,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/NP_056902.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P11204,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYWRVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. The carrier was composed of Palmitic Acid. ","Table 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,5,5,100,"Highest number of responders was observed 1 week after viral challenge. Positive response was also observed in most horses one week after completion of the immunization.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",EIVYFAWVPGHKGIYG,"EIAV pol (704-719)",704,719,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/NP_056902.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P11204,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474100,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/56263,"Linear peptide",RVEDVMNTTEYW,"EIAV env (195-206)",,,195,206,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",RVEDVMNTTEYW,"EIAV env (195-206)",195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYWRVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. The carrier was composed of Palmitic Acid. ","Table 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,5,1,20,"Highest number of responders was observed 1 week after viral challenge.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",RVEDVMNTTEYW,"EIAV env (195-206)",195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474103,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/31824,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"EIAV gag (13-32)",,,13,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"EIAV gag (13-32)",13,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,,13,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYW RVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. PBMCs were re-stimulated in vitro with the epitope for 7 days prior to assay. The carrier was composed of Palmitic Acid. ","Figure 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,5,5,100,"CTL lysed peptide-pulsed target cells. Highest number of responders was observed 1 week after viral challenge. Positive response was also observed in most horses one week after completion of the immunization.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"EIAV gag (13-32)",13,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1474119,http://www.iedb.org/reference/1006064,Literature,16085917,,"Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire","Clin Diagn Lab Immunol",2005,"Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.",http://www.iedb.org/epitope/56263,"Linear peptide",RVEDVMNTTEYW,"EIAV env (195-206)",,,195,206,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3.5-17 months",,"Administration in vivo",,,,Epitope,"Linear peptide",RVEDVMNTTEYW,"EIAV env (195-206)",195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"5 doses of 8.9 mg, administered at intervals of 2 weeks.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RVEDVMNTTEYW,,195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Horses were immunized with a mixture of lipopeptides derived from proteins of equine infectious anemia virus. The peptides were: gag 221-245 (QGPIPMTARFIRGLGVPRERQMEPA), gag 250-269 (RQTYRQWIIEAMSEGIKVMI), gag 13-32 (KLEKVTVQGSQKLTTGNCNW), pol 326-347(LPQGFVLSPYIYQKTLQEILQP), pol 704-719 (EIVYFAWVPGHKGIYG), env 195-206 (RVEDVMNTTEYW), and pol704-env195 (EIVYFAWVPGHKGIYGPGPGRVEDVMNTTEYW RVEDVMNTTEYW). The first dose was in CFA, while booster doses were in IFA. Two weeks later, immunized horses were challenged intravenously with pathogenic pony-virulent strain of equine infectious anemia virus. PBMCs were obtained one week after the last booster dose, and 1 and 3 weeks after virus challenge. PBMCs were re-stimulated in vitro with the epitope for 7 days prior to assay. The carrier was composed of Palmitic Acid. ","Figure 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,5,4,80,"CTL lysed peptide-pulsed target cells. Highest number of responders was observed 1 week after viral challenge. Positive response was also observed in most horses one week after completion of the immunization.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RVEDVMNTTEYW,"EIAV env (195-206)",195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1476762,http://www.iedb.org/reference/1007968,Literature,16154240,,"Alexandra Fluri; Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Shiv Charan; André Busato; Gianfranco Pancino; Ernst Peterhans; Gabriela Obexer-Ruff; Giuseppe Bertoni",Vaccine,2006,"The MHC-haplotype influences primary, but not memory, immune responses to an immunodominant peptide containing T- and B-cell epitopes of the caprine arthritis encephalitis virus Gag protein.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV gag peptide",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,,,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's complete;Freund's incomplete (IFA);",intramuscular,"2 doses at day 0 and day 21",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 5",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,12,8,66.7,"The proliferative response of cells from the Be10-D2 MHC goats was more vigorous than that of cells from Be1-D5 homozygous animals.  After 5 years, with a boost of epitope, 4 of 5 animals had a response independent of MHC background.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class II",http://purl.obolibrary.org/obo/MRO_0001461,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1476763,http://www.iedb.org/reference/1007968,Literature,16154240,,"Alexandra Fluri; Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Shiv Charan; André Busato; Gianfranco Pancino; Ernst Peterhans; Gabriela Obexer-Ruff; Giuseppe Bertoni",Vaccine,2006,"The MHC-haplotype influences primary, but not memory, immune responses to an immunodominant peptide containing T- and B-cell epitopes of the caprine arthritis encephalitis virus Gag protein.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV gag peptide",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,,,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Caprine arthritis encephalitis virus (Caprine arthritis-encephalitis virus)",,,,,,,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.","Text p 602-603",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,6,3,50,"The proliferative response of cells from experimentally infected goats was determined.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class II",http://purl.obolibrary.org/obo/MRO_0001461,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1476764,http://www.iedb.org/reference/1007968,Literature,16154240,,"Alexandra Fluri; Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Shiv Charan; André Busato; Gianfranco Pancino; Ernst Peterhans; Gabriela Obexer-Ruff; Giuseppe Bertoni",Vaccine,2006,"The MHC-haplotype influences primary, but not memory, immune responses to an immunodominant peptide containing T- and B-cell epitopes of the caprine arthritis encephalitis virus Gag protein.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV gag peptide",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,,,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Caprine arthritis encephalitis virus (Caprine arthritis-encephalitis virus)",,,,,,,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,,,,"Occurrence of autoimmune disease","experimental arthritis",https://ontology.iedb.org/ontology/ONTIE_0003429,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Text p 602-603",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,6,4,66.7,"The proliferative response of cells from naturally infected goats was determined.  Three of 3 long-term infected arthritic animals reacted to the epitope, while 1 of 3 asymptomatic but infected animals reacted.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class II",http://purl.obolibrary.org/obo/MRO_0001461,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1477691,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"Gag 221-245",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,15,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1477696,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"Gag 242-261",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,9,60,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1477698,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/55500,"Linear peptide",RQTYRQWIIEAMSEGIKVMI,"Gag 250-269",,,250,269,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,11,73.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",RQTYRQWIIEAMSEGIKVMI,,250,269,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1477699,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"Pol 323-344",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,12,80,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1477700,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/38646,"Linear peptide",LPQGFVLSPYIYQKTLQEILQP,"Pol 326-347",,,326,347,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/NP_056902.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P11204,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,14,93.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",LPQGFVLSPYIYQKTLQEILQP,,326,347,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/NP_056902.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P11204,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1477701,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/12612,"Linear peptide",EIVYFAWVPGHKGIYG,"Pol 704-719",,,704,719,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/NP_056902.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P11204,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,14,93.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",EIVYFAWVPGHKGIYG,,704,719,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/NP_056902.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P11204,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1477702,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/31824,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"Gag 13-32",,,13,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,10,66.7,"The minimal CTL epitope is GSQKLTTGNCNW.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,,13,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1477703,http://www.iedb.org/reference/1008045,Literature,12942208,,"Darrilyn G Fraser; Robert H Mealey; Travis C McGuire",Immunogenetics,2003,"Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.",http://www.iedb.org/epitope/56263,"Linear peptide",RVEDVMNTTEYW,"ENV PV 195-206",,,195,206,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The details of the immunization procedure were not described.  Horses were infected with WSU5, WY, or PV strains of the virus.","Table 3, 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,15,6,40,"The  epitope is also the minimal CTL epitope.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",RVEDVMNTTEYW,,195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1479675,http://www.iedb.org/reference/1007990,Literature,17082657,,"Robert H Mealey; Jae-Hyung Lee; Steven R Leib; Matt H Littke; Travis C McGuire","J Immunol",2006,"A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,Env-RW12,,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,F,"7-8 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 10^7 TCID50",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Mononuclear cell",http://purl.obolibrary.org/obo/CL_0000842,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Figures 1, 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"Lysis was observed with EK target cells from Arabian horses or human cells expressing equine MHC I molecules 7-6 or 141, which differs from 7-6 molecules in a single residues in alpha-2 domain.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,,,Other,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1479677,http://www.iedb.org/reference/1007990,Literature,17082657,,"Robert H Mealey; Jae-Hyung Lee; Steven R Leib; Matt H Littke; Travis C McGuire","J Immunol",2006,"A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,Gag-GW12,,,47,58,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,F,"7-8 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 10^7 TCID50",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Mononuclear cell",http://purl.obolibrary.org/obo/CL_0000842,Epitope,"Linear peptide",GSQKLTTGNCNW,,47,58,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Figures 1, 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"Lysis was obtained with human APCs expressed equine MHC I molecules 7-6 and not 141 molecule, which differs from 7-6 molecules at a single residues in the alpha-2 domain.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,,,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",GSQKLTTGNCNW,,47,58,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1479679,http://www.iedb.org/reference/1007990,Literature,17082657,,"Robert H Mealey; Jae-Hyung Lee; Steven R Leib; Matt H Littke; Travis C McGuire","J Immunol",2006,"A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.",http://www.iedb.org/epitope/50248,"Linear peptide",QAEVLQERLEW,Rev-QW11,,,57,67,,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,F,"7-8 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 10^7 TCID50",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Mononuclear cell",http://purl.obolibrary.org/obo/CL_0000842,Epitope,"Linear peptide",QAEVLQERLEW,,57,67,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Figures 1, 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"Lysis was observed with EK target cells from Arabian horses or human cells expressing equine MHC I molecules 7-6 or 141, which differs from 7-6 molecules in a single residues in alpha-2 domain.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,,,Other,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",QAEVLQERLEW,,57,67,,"rev protein",http://www.ncbi.nlm.nih.gov/protein/AAP34944.1,"Protein Rev",,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483128,http://www.iedb.org/reference/1008041,Literature,12902502,,"Travis C McGuire; Steven R Leib; Robert H Mealey; Darrilyn G Fraser; David J Prieur","J Immunol",2003,"Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,Env-RW12,,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P22429.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,M,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Mononuclear cell",http://purl.obolibrary.org/obo/CL_0000842,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P22429.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Effector cells were from an Arabian horse heterozygous for the SCID trait.","Table 1, Figures 3, 4, 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,"Lysis was also observed with peptide-pulsed heterologous kidney cells and human B lymphoblastoid cells transduced with retroviral vectors expressing equine ELA-A1. Freshly isolated effector cells (without in vitro restimulation) also lysed peptide-pulsed target cells.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P22429.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483133,http://www.iedb.org/reference/1008041,Literature,12902502,,"Travis C McGuire; Steven R Leib; Robert H Mealey; Darrilyn G Fraser; David J Prieur","J Immunol",2003,"Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,Env-GW12,,,21,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,M,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Mononuclear cell",http://purl.obolibrary.org/obo/CL_0000842,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"Effector cells were from an Arabian horse heterozygous for the SCID trait.","Table 1, Figures 5, 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,"Lysis was also observed with peptide-pulsed heterologous kidney cells and human B lymphoblastoid cells transduced with retroviral vectors expressing equine ELA-A1. Freshly isolated effector cells (without in vitro restimulation) also lysed peptide-pulsed target cells.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483559,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 8-87 months at time of first assay.","Tables 1, 2, 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,9,6,66.7,"Assays were also performed with CD4-depleted and CD8-depleted cells. CD4-T lymphocytes were shown to be necessary for proliferation.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483561,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Equine infectious anemia virus (ISOLATE WYOMING)",,,,,,,,,"Equine infectious anemia virus (ISOLATE WYOMING)",http://purl.obolibrary.org/obo/NCBITaxon_11672,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The mixed breed pony was infected for 7 months at time of first assay.","Tables 1",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483564,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,2,2,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8-",http://purl.obolibrary.org/obo/OBI_1110051,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483565,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 39-87 months at time of first assay.","Table 4","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,4,2,50,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483566,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 39-87 months at time of first assay.","Table 4","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Negative,,,4,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483570,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"gag (242-261)",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 8-87 months at time of first assay.","Tables 1, 2, 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,9,5,55.6,"Assays were also performed with CD4-depleted and CD8-depleted cells. CD4-T lymphocytes were shown to be necessary for proliferation.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483571,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"gag (242-261)",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The mixed breed pony was infected for 7 months at time of first assay.","Tables 1",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,1,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483572,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"gag (242-261)",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,2,2,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8-",http://purl.obolibrary.org/obo/OBI_1110051,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8-",http://purl.obolibrary.org/obo/OBI_1110051,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483573,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"gag (242-261)",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 39-87 months at time of first assay.","Table 4","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,4,3,75,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483574,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"gag (242-261)",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 39-87 months at time of first assay.","Table 4","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Negative,,,4,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483575,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"gag (242-261)",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse was infected for 6 months at time of first assay.","Figure 2","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483576,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"gag (242-261)",,,242,261,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse was infected for 6 months at time of first assay.","Figure 3","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Negative,,,1,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483580,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"pol (323-344)",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 8-87 months at time of first assay.","Tables 1, 2, 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,9,4,44.4,"Assays were also performed with CD4-depleted and CD8-depleted cells. CD4-T lymphocytes were shown to be necessary for proliferation.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483581,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"pol (323-344)",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Equine infectious anemia virus (ISOLATE WYOMING)",,,,,,,,,"Equine infectious anemia virus (ISOLATE WYOMING)",http://purl.obolibrary.org/obo/NCBITaxon_11672,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The mixed breed pony was infected for 7 months at time of first assay.","Tables 1",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,1,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483582,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"pol (323-344)",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 39-87 months at time of first assay.","Table 4","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,4,1,25,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483583,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"pol (323-344)",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mixed breed ponies were infected for 39-87 months at time of first assay.","Table 4","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Negative,,,4,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483584,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"pol (323-344)",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse was infected for 6 months at time of first assay.","Figure 3","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483585,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"pol (323-344)",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse was infected for 6 months at time of first assay.","Figure 3","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483586,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/72881,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,"pol (323-344)",,,323,344,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,2,2,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8-",http://purl.obolibrary.org/obo/OBI_1110051,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8-",http://purl.obolibrary.org/obo/OBI_1110051,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,II,Epitope,"Linear peptide",WNCLPQGFVLSPYIYQKTLQEI,,323,344,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59862.1,"Pol polyprotein",http://www.uniprot.org/uniprot/P32542,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483588,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse was infected for 6 months at time of first assay.","Figure 2","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483589,http://www.iedb.org/reference/1006373,Literature,11918691,,"Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire",Immunology,2002,"Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"gag (221-245)",,,221,245,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse was infected for 6 months at time of first assay.","Figure 3","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Negative,,,1,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483592,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,"P15 (2j)",,,21,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus PV",,,,,,,,,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 300 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"One of the horses was a 4-month old foal. Two of the horses received a series of injection with peptides derived from EIAV envelope protein prior to infection with the infectious dose of EIAV strain PV.","Table 3, Figures 8, 9","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,5,5,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483593,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,"P15 (2j)",,,21,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Pam3Cys (lipoprotein);",,"8 doses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse received 90 mg immunogen (lipopeptide) given in 10 inoculations intramuscularly, subcutaneously and intradermally. The horse was challenged by intravenous injection with 300 TCID50 EIAV strain PV 8 days after the final lipopeptide injection.","Table 3, Figures 8, 9","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483594,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,"P15 (2j)",,,21,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Pam3Cys (lipoprotein);",,"8 doses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horse received 90 mg immunogen (lipopeptide) given in 10 inoculations intramuscularly, subcutaneously and intradermally. The horse was challenged by intravenous injection with 300 TCID50 EIAV strain PV 8 days after the final lipopeptide injection.","Table 3, Figure 9","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,"Taxonomic Child",Organism,"Equine infectious anemia virus PV",,,,,,,,,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483685,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,"SU (WSU5)",,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Pam3Cys (lipoprotein);",,"8 doses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horses received 60 mg lipopeptide carrying the epitope given in 8 inoculations intramuscularly, subcutaneously and intradermally. The horses then received 30 mg lipopeptide carrying sequence RVEDVMNTTEYW (from Env of EIAV strain PV) given in 2 inoculations by the same routes. The horses were challenged by intravenous injection with 300 TCID50 EIAV strain PV 8 days after the final lipopeptide injection.","Figure 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,3,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483691,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,"SU (WSU5)",,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483692,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,"SU (WSU5)",,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Pam3Cys (lipoprotein);",,"8 doses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horses received 60 mg lipopeptide carrying the epitope given in 8 inoculations intramuscularly, subcutaneously and intradermally. The horses then received 30 mg lipopeptide carrying sequence RVEDVMNTTEYW (from Env of EIAV strain PV) given in 2 inoculations by the same routes. The horses were challenged by intravenous injection with 300 TCID50 EIAV strain PV 8 days after the final lipopeptide injection.","Figure 9","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,3,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,"Taxonomic Sibling",Organism,"Equine infectious anemia virus PV",,,,,,,,,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483708,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/56263,"Linear peptide",RVEDVMNTTEYW,"SU (PV)",,,195,206,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/ontology/ONTIE_0000408,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,Adult,,"Administration in vivo",,,,"Taxonomic Sibling",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",RVEDVMNTTEYW,,195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483710,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/56263,"Linear peptide",RVEDVMNTTEYW,"SU (PV)",,,195,206,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/ontology/ONTIE_0000408,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,Epitope,"Linear peptide",RVEDVMNTTEYW,,195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Pam3Cys (lipoprotein);",,"8 doses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horses received 60 mg lipopeptide carrying sequence RVEDVTNTAEYW (from Env of EIAV strain WSU5) given in 8 inoculations intramuscularly, subcutaneously and intradermally. The horses then received 30 mg  lipopeptide carrying the epitope given in 2 inoculations by the same routes. The horses were challenged by intravenous injection with 300 TCID50 EIAV strain PV 8 days after the final lipopeptide injection.","Table 3, Figure 9","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,3,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,"Source Organism",Organism,"Equine infectious anemia virus PV",,,,,,,,,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483712,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/56263,"Linear peptide",RVEDVMNTTEYW,"SU (PV)",,,195,206,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/ontology/ONTIE_0000408,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,Epitope,"Linear peptide",RVEDVMNTTEYW,,195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,";Pam3Cys (lipoprotein);",,"8 doses",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"The horses received 60 mg lipopeptide carrying sequence RVEDVTNTAEYW (from Env of EIAV strain WSU5) given in 8 inoculations intramuscularly, subcutaneously and intradermally. The horse then received 30 mg of the lipopeptide carrying the eptiope given in 2 inoculation by the same routes. The horses were challenged by intravenous injection with 300 TCID50 EIAV strain PV 8 days after the final lipopeptide injection.","Table 3, Figure 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,3,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",RVEDVMNTTEYW,,195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1483722,http://www.iedb.org/reference/1006365,Literature,12531649,,"Sherritta L Ridgely; Baoshan Zhang; Travis C McGuire",Vaccine,2003,"Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.",http://www.iedb.org/epitope/56263,"Linear peptide",RVEDVMNTTEYW,"SU (PV)",,,195,206,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/ontology/ONTIE_0000408,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,Adult,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus PV",,,,,,,,,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Horses were infected by intravenous injection with 300 TCID50 EIAV strain PV.","Table 3, Figure 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,3,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",RVEDVMNTTEYW,,195,206,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus PV",https://ontology.iedb.org/taxon/10000499,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1489069,http://www.iedb.org/reference/1006280,Literature,15979679,,"Robert H Mealey; Amin Sharif; Shirley A Ellis; Matt H Littke; Steven R Leib; Travis C McGuire",Virology,2005,"Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,Env-RW12,,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"2 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 10^7 TCID50 of the WSU5 of EIAV",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Figures 1, 2, 5",multimer/tetramer,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_1110179,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,,,,,,"ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1489070,http://www.iedb.org/reference/1006280,Literature,15979679,,"Robert H Mealey; Amin Sharif; Shirley A Ellis; Matt H Littke; Steven R Leib; Travis C McGuire",Virology,2005,"Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,Gag-GW12,,,21,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"2 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 10^7 TCID50 of the WSU5 of EIAV",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Figures 2, 5",multimer/tetramer,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_1110179,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,,,,,,"ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1489071,http://www.iedb.org/reference/1006280,Literature,15979679,,"Robert H Mealey; Amin Sharif; Shirley A Ellis; Matt H Littke; Steven R Leib; Travis C McGuire",Virology,2005,"Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.",http://www.iedb.org/epitope/56268,"Linear peptide",RVEDVTNTAEYW,Env-RW12,,,195,206,,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"2 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 10^7 TCID50 of the WSU5 of EIAV",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Figure 8","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"Reduced lysis was observed with epitope variants A9V, D4H, T6M. However, increased lysis was observed with epitope variant A9T.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",RVEDVTNTAEYW,,195,206,,"Envelope glycoprotein precursor (Env polyprotein)",http://www.ncbi.nlm.nih.gov/protein/P16082.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1489073,http://www.iedb.org/reference/1006280,Literature,15979679,,"Robert H Mealey; Amin Sharif; Shirley A Ellis; Matt H Littke; Steven R Leib; Travis C McGuire",Virology,2005,"Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,Gag-GW12,,,21,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus Arabian",https://ontology.iedb.org/ontology/ONTIE_0000809,,,,"2 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,intravenous,"1 dose of 10^7 TCID50 of the WSU5 of EIAV",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Table 1, Figure 9","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",GSQKLTTGNCNW,,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1492158,http://www.iedb.org/reference/1006294,Literature,11906769,,"Sherritta L Ridgely; Travis C McGuire",Vaccine,2002,"Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.",http://www.iedb.org/epitope/24470,"Linear peptide",HPLPNAPLV,"Gag p26 18a",,,235,243,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"107 or 108 50% TCID",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",HPLPNAPLVAP,,235,245,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Figures 2 and 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,2,2,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,"Adherent cell",http://purl.obolibrary.org/obo/OBI_1110043,"Direct Ex Vivo","ELA-A5 class I",http://purl.obolibrary.org/obo/MRO_0001862,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",HPLPNAPLV,,235,243,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1492167,http://www.iedb.org/reference/1006294,Literature,11906769,,"Sherritta L Ridgely; Travis C McGuire",Vaccine,2002,"Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.",http://www.iedb.org/epitope/22854,"Linear peptide",GTTKQKMML,"Gag p26 28b1",,,372,380,,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"107 or 108 50% TCID",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide",GTTKQKMMLLA,,372,382,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,"Adherent cell",http://purl.obolibrary.org/obo/OBI_1110043,"Direct Ex Vivo","ELA-A9 class I",http://purl.obolibrary.org/obo/MRO_0001866,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",GTTKQKMML,,372,380,,gag,http://www.ncbi.nlm.nih.gov/protein/AAA43011.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1492168,http://www.iedb.org/reference/1006294,Literature,11906769,,"Sherritta L Ridgely; Travis C McGuire",Vaccine,2002,"Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.",http://www.iedb.org/epitope/56269,"Linear peptide",RVEDVTNTAEYWGF,"Env SU 14-mer",,,14,27,,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAX56996.1,"Envelope protein gp90 (Fragment)",http://www.uniprot.org/uniprot/Q6QWT0,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"107 or 108 50% TCID",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RVEDVTNTAEYWGF,,14,27,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAX56996.1,"Envelope protein gp90 (Fragment)",http://www.uniprot.org/uniprot/Q6QWT0,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,,"Figures 6 and 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,1,1,100,"Epitope-restimulated PBMCs from equine infectious anemia virus-infected horses lysed target cells pulsed with the epitope (either as a free peptide or as a MAP-lipopeptide construct).",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Short Term Restimulated",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,"Adherent cell",http://purl.obolibrary.org/obo/OBI_1110043,"Direct Ex Vivo","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",RVEDVTNTAEYWGF,,14,27,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAX56996.1,"Envelope protein gp90 (Fragment)",http://www.uniprot.org/uniprot/Q6QWT0,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498380,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/53137,"Linear peptide",RAKYEKKTANK,RK11,,,105,115,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RAKYEKKTANK,RK11,105,115,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2 and figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was high: 7.9 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RAKYEKKTANK,RK11,105,115,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498392,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/33298,"Linear peptide",KSEGHPQEISKF,KF12,,,297,308,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",KSEGHPQEISKF,KF12,297,308,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was high: 3.7 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Not determined",,I,Epitope,"Linear peptide",KSEGHPQEISKF,KF12,297,308,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498393,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/75277,"Linear peptide",YPEFVDRLLSQI,YI12,,,285,296,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-W11 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",YPEFVDRLLSQI,YI12,285,296,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was high: 2.7 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",YPEFVDRLLSQI,YI12,285,296,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498394,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/18138,"Linear peptide",FVDRLLSQIKSE,FE12,,,288,299,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-W11 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",FVDRLLSQIKSE,FE12,288,299,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was high: 9.9 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",FVDRLLSQIKSE,FE12,288,299,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498395,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/26899,"Linear peptide",IKSEGHPQEI,II10,,,296,305,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-W11 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IKSEGHPQEI,II10,296,305,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was high: 0.9 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IKSEGHPQEI,II10,296,305,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498484,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/22467,"Linear peptide",GSQKLTTGNCNW,GW12,,,21,32,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-W11 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GSQKLTTGNCNW,GW12,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was high: 3.9 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes. The functional avidity of CTL recognition of this peptide was high: 10.9 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",GSQKLTTGNCNW,GW12,21,32,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498485,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/29862,"Linear peptide",KALKKLEKV,KV9,,,9,17,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",KALKKLEKV,KV9,9,17,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2 and figure 3, 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was moderate: 71.3 nM. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes. Synthetic peptides generated to represent the sequence of EIAV variants were used to show that the K to R change at position 4 of this peptide resulted in CTL escape in EIAV- infected horse.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KALKKLEKV,KV9,9,17,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498486,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/7736,"Linear peptide",DCTSEEMNAF,DF10,,,171,180,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",DCTSEEMNAF,DF10,171,180,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A1 class I",http://purl.obolibrary.org/obo/MRO_0001859,"Not determined",,I,Epitope,"Linear peptide",DCTSEEMNAF,DF10,171,180,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498489,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/32318,"Linear peptide",KMGLQINNVVDG,KG12,,,86,97,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I;ELA-W11 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",KMGLQINNVVDG,KG12,86,97,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KMGLQINNVVDG,KG12,86,97,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498490,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/73692,"Linear peptide",YEKKTANK,YK8,,,108,115,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A6 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",YEKKTANK,YK8,108,115,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2 and figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes. Synthetic peptides generated to represent the sequence of EIAV variants were used to show that the K to R change at position 3 in YK8 resulted in CTL escape from EIAV -infected horse.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A6 class I",http://purl.obolibrary.org/obo/MRO_0001863,"Not determined",,I,Epitope,"Linear peptide",YEKKTANK,YK8,108,115,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498491,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/42465,"Linear peptide",MRHLRPEDTL,ML10,,,326,335,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A6 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",MRHLRPEDTL,ML10,326,335,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A6 class I",http://purl.obolibrary.org/obo/MRO_0001863,"Not determined",,I,Epitope,"Linear peptide",MRHLRPEDTL,ML10,326,335,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498492,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/55140,"Linear peptide",RPEDTLEEKMYA,RA12,,,330,341,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A6 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RPEDTLEEKMYA,RA12,330,341,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A6 class I",http://purl.obolibrary.org/obo/MRO_0001863,"Not determined",,I,Epitope,"Linear peptide",RPEDTLEEKMYA,RA12,330,341,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498493,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/11449,"Linear peptide",EDTLEEKMYACR,ER12,,,332,343,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A6 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",EDTLEEKMYACR,ER12,332,343,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A6 class I",http://purl.obolibrary.org/obo/MRO_0001863,"Not determined",,I,Epitope,"Linear peptide",EDTLEEKMYACR,ER12,332,343,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498494,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/73338,"Linear peptide",YACRDIGTTKQK,YK12,,,340,351,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A6 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",YACRDIGTTKQK,YK12,340,351,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A6 class I",http://purl.obolibrary.org/obo/MRO_0001863,"Not determined",,I,Epitope,"Linear peptide",YACRDIGTTKQK,YK12,340,351,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498496,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/43588,"Linear peptide",NEECRNAMRHLR,NR12,,,319,330,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A3 class I;ELA-A5 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NEECRNAMRHLR,NR12,319,330,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NEECRNAMRHLR,DF10,319,330,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498497,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/26331,"Linear peptide",IGTTKQKMM,IM9,,,345,353,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A3 class I;ELA-A5 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IGTTKQKMM,IM9,345,353,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IGTTKQKMM,IM9,345,353,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498498,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/56228,"Linear peptide",RTWWAISAVK,RK10,,,77,86,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RTWWAISAVK,DF10,77,86,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",RTWWAISAVK,RK10,77,86,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498499,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/73240,"Linear peptide",WWAISAVKMGL,WL11,,,79,89,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",WWAISAVKMGL,WL11,79,89,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",WWAISAVKMGL,WL11,79,89,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498500,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/72235,"Linear peptide",WAISAVKMGLQI,WI12,,,80,91,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",WAISAVKMGLQI,WI12,80,91,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",WAISAVKMGLQI,WI12,80,91,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002038,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498501,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/20324,"Linear peptide",GIKVMIGKPKAQ,GQ12,,,264,275,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GIKVMIGKPKAQ,GQ12,264,275,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",GIKVMIGKPKAQ,GQ12,264,275,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498502,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/47280,"Linear peptide",PEFVDRLLSQ,PQ10,,,286,295,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",PEFVDRLLSQ,PQ10,286,295,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",PEFVDRLLSQ,PQ10,286,295,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498503,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/54665,"Linear peptide",RLLSQIKSEG,RG10,,,291,300,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RLLSQIKSEG,RG10,291,300,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",RLLSQIKSEG,RG10,291,300,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1498504,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/65094,"Linear peptide",TLTIQNANEECR,TR12,,,312,323,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A4 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",TLTIQNANEECR,TR12,312,323,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A4 class I",http://purl.obolibrary.org/obo/MRO_0001861,"Not determined",,I,Epitope,"Linear peptide",TLTIQNANEECR,TR12,312,323,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1499193,http://www.iedb.org/reference/1006462,Literature,16139857,,"Chungwon Chung; Robert H Mealey; Travis C McGuire",Virology,2005,"Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.",http://www.iedb.org/epitope/10006,"Linear peptide",DRLLSQIKSE,DE10,,,290,299,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A9 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)",EIAV,,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",DRLLSQIKSE,DE10,290,299,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"PBMC from each infected horse were stimulated with a pool of 15-16 amino acid peptides containing this peptide.","Table 2 and figure 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,"The functional avidity of CTL recognition of this peptide was low: > 1000 nm. Not all carrier horses had high functional avidity CTL to Gag EC, but those that did had longer periods without disease episodes. Synthetic peptides generated to represent the sequence of EIAV variants were used to show that the R to K change at position 4 resulted in CTL escape from EIAV -infected horse.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Embryo,http://purl.obolibrary.org/obo/UBERON_0000922,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A9 class I",http://purl.obolibrary.org/obo/MRO_0001866,"Not determined",,I,Epitope,"Linear peptide",DRLLSQIKSE,DE10,290,299,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1503686,http://www.iedb.org/reference/1006453,Literature,17412991,,"Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Gabriela Obexer-Ruff; Marcus G Doherr; Reto Zanoni; Ernst Peterhans; Giuseppe Bertoni","J Gen Virol",2007,"Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV Gag(146-167)",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Sequence of the epitope can be found in Fluri et. al., Vaccine 24, 597–606 (2006).",,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's incomplete (IFA);",intramuscular,"2 doses of 100 ug, administered at intervals of 21 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 1","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0001475,Positive,,,,,,"The epitope protects goats from CAEV challenge as measured by decreased viral load.",,,,,,,,,,,,,,,,,,"Taxonomic Child",Organism,"Caprine arthritis encephalitis virus strain Cork (Caprine arthritis encephalitis virus (STRAIN CORK))",,,,,,,,,"Caprine arthritis encephalitis virus strain Cork",http://purl.obolibrary.org/obo/NCBITaxon_11661,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1503690,http://www.iedb.org/reference/1006453,Literature,17412991,,"Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Gabriela Obexer-Ruff; Marcus G Doherr; Reto Zanoni; Ernst Peterhans; Giuseppe Bertoni","J Gen Virol",2007,"Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV Gag(146-167)",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Sequence of the epitope can be found in Fluri et. al., Vaccine 24, 597–606 (2006).",,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's incomplete (IFA);",intramuscular,"2 doses of 100 ug, administered at intervals of 21 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2a and 2d","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,,,,"At 55 days post-infection, the proviral load in PBMCs of vaccinated goats correlated strongly with IFN-g and IL-4 mRNA expression by PBMCs stimulated with whole-virus preparation.  The authors concluded that the inefficient control of CAEV replication in vaccinated goats did not depend on either IFN-g or IL-4.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,"Taxonomic Child",Organism,"Caprine arthritis encephalitis virus strain Cork (Caprine arthritis encephalitis virus (STRAIN CORK))",,,,,,,,,"Caprine arthritis encephalitis virus strain Cork",http://purl.obolibrary.org/obo/NCBITaxon_11661,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1503692,http://www.iedb.org/reference/1006453,Literature,17412991,,"Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Gabriela Obexer-Ruff; Marcus G Doherr; Reto Zanoni; Ernst Peterhans; Giuseppe Bertoni","J Gen Virol",2007,"Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV Gag(146-167)",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Sequence of the epitope can be found in Fluri et. al., Vaccine 24, 597–606 (2006).",,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's incomplete (IFA);",intramuscular,"2 doses of 100 ug, administered at intervals of 21 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 2b anad 2d","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Positive,,,,,,"At 55 days post-infection, the proviral load in PBMCs of vaccinated goats correlated strongly with IFN-g and IL-4 mRNA expression by PBMCs stimulated with whole-virus preparation.  The authors concluded that the inefficient control of CAEV replication in vaccinated goats did not depend on either IFN-g or IL-4.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class II",http://purl.obolibrary.org/obo/MRO_0001461,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,"Taxonomic Child",Organism,"Caprine arthritis encephalitis virus strain Cork (Caprine arthritis encephalitis virus (STRAIN CORK))",,,,,,,,,"Caprine arthritis encephalitis virus strain Cork",http://purl.obolibrary.org/obo/NCBITaxon_11661,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1503697,http://www.iedb.org/reference/1006453,Literature,17412991,,"Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Gabriela Obexer-Ruff; Marcus G Doherr; Reto Zanoni; Ernst Peterhans; Giuseppe Bertoni","J Gen Virol",2007,"Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV Gag(146-167)",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Sequence of the epitope can be found in Fluri et. al., Vaccine 24, 597–606 (2006).",,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's incomplete (IFA);",intramuscular,"2 doses of 100 ug, administered at intervals of 21 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2c","RNA/DNA detection","IFNg release",,http://purl.obolibrary.org/obo/OBI_0001350,Positive,,,,,,"At day 55 post-infection, a highly significant correlation between IL-4 and IFN-g mRNA expression was observed following stimulation with the epitope.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1503698,http://www.iedb.org/reference/1006453,Literature,17412991,,"Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Gabriela Obexer-Ruff; Marcus G Doherr; Reto Zanoni; Ernst Peterhans; Giuseppe Bertoni","J Gen Virol",2007,"Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV Gag(146-167)",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Sequence of the epitope can be found in Fluri et. al., Vaccine 24, 597–606 (2006).",,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's incomplete (IFA);",intramuscular,"2 doses of 100 ug, administered at intervals of 21 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2c","RNA/DNA detection","IL-4 release",,http://purl.obolibrary.org/obo/OBI_0001339,Positive,,,,,,"At day 55 post-infection, a highly significant correlation between IL-4 and IFN-g mRNA expression was observed following stimulation with the epitope.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","H2 class II",http://purl.obolibrary.org/obo/MRO_0001461,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1503699,http://www.iedb.org/reference/1006453,Literature,17412991,,"Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Gabriela Obexer-Ruff; Marcus G Doherr; Reto Zanoni; Ernst Peterhans; Giuseppe Bertoni","J Gen Virol",2007,"Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV Gag(146-167)",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Sequence of the epitope can be found in Fluri et. al., Vaccine 24, 597–606 (2006).",,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's incomplete (IFA);",intramuscular,"2 doses of 100 ug, administered at intervals of 21 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","RNA/DNA detection","GM-CSF release",,http://purl.obolibrary.org/obo/OBI_0001357,Positive,,,,,,"At 55 days post-infection, a significant correlation between the proviral load and GM-CSF, and between GM-CSF and either IFN-g or IL-4 mRNA,  was observed in vaccinated goats following PBMC stimulation with either the peptide or whole virus.  The authors suggested that CM-CSF is a key cytokine driving virus replication in the early phase of infection.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1503711,http://www.iedb.org/reference/1006453,Literature,17412991,,"Chiara Nenci; Marie-Luise Zahno; Hans-Rudolf Vogt; Gabriela Obexer-Ruff; Marcus G Doherr; Reto Zanoni; Ernst Peterhans; Giuseppe Bertoni","J Gen Virol",2007,"Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo.",http://www.iedb.org/epitope/33018,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,"CAEV Gag(146-167)",,,289,310,,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Sequence of the epitope can be found in Fluri et. al., Vaccine 24, 597–606 (2006).",,,,,,,,,,,,,,,,"Capra hircus Saanen",https://ontology.iedb.org/ontology/ONTIE_0000116,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",KQKTNEPYEDFAARLLEAIDAE,,289,310,,"gag protein",https://ontology.iedb.org/ontology/ONTIE_0002075,,,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660,";Freund's incomplete (IFA);",intramuscular,"2 doses of 100 ug, administered at intervals of 21 days.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","RNA/DNA detection","GM-CSF release",,http://purl.obolibrary.org/obo/OBI_0001357,Positive,,,,,,"At 55 days post-infection, a significant correlation between the proviral load and GM-CSF, and between GM-CSF and either IFN-g or IL-4 mRNA,  was observed in vaccinated goats following PBMC stimulation with either the peptide or whole virus.  The authors suggested that CM-CSF is a key cytokine driving virus replication in the early phase of infection.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,"Taxonomic Child",Organism,"Caprine arthritis encephalitis virus strain Cork (Caprine arthritis encephalitis virus (STRAIN CORK))",,,,,,,,,"Caprine arthritis encephalitis virus strain Cork",http://purl.obolibrary.org/obo/NCBITaxon_11661,"Caprine arthritis encephalitis virus",http://purl.obolibrary.org/obo/NCBITaxon_11660
http://www.iedb.org/assay/1509390,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79930,"Linear peptide",MGDPLTWSKALKKLEKVTVQ,"EIAV p15 1 1–20",,,1,20,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I;ELA-A7 class I;ELA-A8 class I;ELA-W11 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,3,75,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",MGDPLTWSKALKKLEKVTVQ,,1,20,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509408,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/31824,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,"EIAV p15 2 13–32",,,13,32,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-W11 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,1,25,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KLEKVTVQGSQKLTTGNCNW,,13,32,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509409,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79921,"Linear peptide",LTTGNCNWALSLVDLFHDTN,"EIAV p15 3 25–44",,,25,44,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I;ELA-W11 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,2,50,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LTTGNCNWALSLVDLFHDTN,,25,44,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509410,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80064,"Linear peptide",VDLFHDTNFVKEKDWQLRDV,"EIAV p15 4 37–56",,,37,56,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,4,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",VDLFHDTNFVKEKDWQLRDV,,37,56,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509411,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79878,"Linear peptide",KDWQLRDVIPLLEDVTQTLS,"EIAV p15 5 49–68",,,49,68,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,4,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KDWQLRDVIPLLEDVTQTLS,,49,68,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509412,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79801,"Linear peptide",EDVTQTLSGQEREAFERTWW,"EIAV p15 6 61–80",,,61,80,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,1,25,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EDVTQTLSGQEREAFERTWW,,61,80,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509413,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79800,"Linear peptide",EAFERTWWAISAVKMGLQIN,"EIAV p15 7 73–92",,,73,92,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,1,25,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EAFERTWWAISAVKMGLQIN,,73,92,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509414,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80082,"Linear peptide",VKMGLQINNVVDGKASFQLL,"EIAV p15 8 85–104",,,85,104,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I;ELA-W11 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,2,50,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",VKMGLQINNVVDGKASFQLL,,85,104,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509415,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79838,"Linear peptide",GKASFQLLRAKYEKKTANKK,"EIAV p15 9 97–116",,,97,116,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,4,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",GKASFQLLRAKYEKKTANKK,,97,116,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509416,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79804,"Linear peptide",EKKTANKKQSEPSEEY,"EIAV p15 10 109–124",,,109,124,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 2","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,1,25,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EKKTANKKQSEPSEEY,,109,124,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509417,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79967,"Linear peptide",PIMIDGAGNRNFRPLTPRGY,"EIAV p26a 11 125–144",,,125,144,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PIMIDGAGNRNFRPLTPRGY,,125,144,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509419,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80015,"Linear peptide",RPLTPRGYTTWVNTIQTNGL,"EIAV p26a 12 137–156",,,137,156,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RPLTPRGYTTWVNTIQTNGL,,137,156,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509420,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79954,"Linear peptide",NTIQTNGLLNEASQNLFGIL,"EIAV p26a 13 149–168",,,149,168,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NTIQTNGLLNEASQNLFGIL,,149,168,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509421,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80033,"Linear peptide",SQNLFGILSVDCTSEEMNAF,"EIAV p26a 14 161–180",,,161,180,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,1,33.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SQNLFGILSVDCTSEEMNAF,,161,180,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509422,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80055,"Linear peptide",TSEEMNAFLDVVPGQAGQKQ,"EIAV p26a 15 173–192",,,173,192,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",TSEEMNAFLDVVPGQAGQKQ,,173,192,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509423,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79962,"Linear peptide",PGQAGQKQILLDAIDKIADD,"EIAV p26a 16 185–204",,,185,204,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,1,33.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PGQAGQKQILLDAIDKIADD,,185,204,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509424,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79747,"Linear peptide",AIDKIADDWDNRHPLPNAPL,"EIAV p26a 17 197–216",,,197,216,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A5 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,1,33.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",AIDKIADDWDNRHPLPNAPL,,197,216,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509425,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/24470,"Linear peptide",HPLPNAPLV,"EIAV p26a 18a 209–217",,,209,217,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 3, 5, 6 and 8","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,3,100,"Various truncations to the sequence HPLPNAPLVAPPQGPIPMTA were made and this epitope was determined to be optimal.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A5 class I",http://purl.obolibrary.org/obo/MRO_0001862,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",HPLPNAPLV,,209,217,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509426,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/50935,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,"EIAV p26a 19 221–245",,,221,245,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 3","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,2,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",QGPIPMTARFIRGLGVPRERQMEPA,,221,245,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509428,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/41417,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,"EIAV p26b 20 242–261",,,242,261,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",MEPAFDQFRQTYRQWIIEAM,,242,261,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509430,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80019,"Linear peptide",RQWIIEAMSEGIKVMIGKPK,"EIAV p26b 21 254–273",,,254,273,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RQWIIEAMSEGIKVMIGKPK,,254,273,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509431,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79895,"Linear peptide",KVMIGKPKAQNIRQGAKEPY,"EIAV p26b 22 266–285",,,266,285,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KVMIGKPKAQNIRQGAKEPY,,266,285,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509432,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80016,"Linear peptide",RQGAKEPYPEFVDRLLSQIK,"EIAV p26b 23 278–297",,,278,297,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-W11 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,1,33.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RQGAKEPYPEFVDRLLSQIK,,278,297,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509433,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79787,"Linear peptide",DRLLSQIKSEGHPQEISKFL,"EIAV p26b 24 290–309",,,290,309,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A1 class I;ELA-A7 class I;ELA-W11 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,2,66.7,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DRLLSQIKSEGHPQEISKFL,,290,309,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509434,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79974,"Linear peptide",PQEISKFLTDTLTIQNANEE,"EIAV p26b 25 302–321",,,302,321,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,"ELA-A7 class I;ELA-W11 class I","Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,1,33.3,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PQEISKFLTDTLTIQNANEE,,302,321,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509435,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/80051,"Linear peptide",TIQNANEECRNAMRHLRPED,"EIAV p26b 26 314–333",,,314,333,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",TIQNANEECRNAMRHLRPED,,314,333,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509436,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/79936,"Linear peptide",MRHLRPEDTLEEKMYACRDI,"EIAV p26b 27 326–345",,,326,345,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,3,0,0,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",MRHLRPEDTLEEKMYACRDI,,326,345,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1509438,http://www.iedb.org/reference/1006710,Literature,9811694,,"W Zhang; S M Lonning; T C McGuire","J Virol",1998,"Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.",http://www.iedb.org/epitope/22854,"Linear peptide",GTTKQKMML,"EIAV p26b 28b-1 346-354",,,346,354,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Equine infectious anemia virus (STRAIN WSU5)",,,,,,,,,"Equine infectious anemia virus (STRAIN WSU5)",http://purl.obolibrary.org/obo/NCBITaxon_11671,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,"10^8 TCID50",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,,"Figures 4, 7 and 9","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,3,2,66.7,"Various truncations to the sequence KMYACRDIGTTKQKMMLLAKAL were made and this epitope was determined to be optimal.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,Other,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","ELA-A9 class I",http://purl.obolibrary.org/obo/MRO_0001866,"T cell assay -Mismatched MHC molecules",http://purl.obolibrary.org/obo/ECO_0008085,I,Epitope,"Linear peptide",GTTKQKMML,,346,354,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAC03760.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P69732,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581701,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/10156,"Linear peptide",DSKNSMAESKEARDQEMNLK,"EV0 peptide 5",,,41,60,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,9,42.9,"The stimulation index of the protected group of ponies (n = 14) was significantly higher than that of the group (n = 7) progressing to disease. One of 7 of the group progressing to disease responded versus 8 of 14 of the protected group. It was not determined if the epitope contains both CTL and T helper epitopes or if the observed proliferation response was due to CTL expansion.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",DSKNSMAESKEARDQEMNLK,,41,60,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581703,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/11878,"Linear peptide",EESKEEKRRNDWWKIGMFLL,"EV0 peptide 7",,,61,80,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,3,14.3,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",EESKEEKRRNDWWKIGMFLL,,61,80,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581705,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/6537,"Linear peptide",CLAGTTGGILWWYEGLPQQH,"EV0 peptide 9",,,81,100,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,8,38.1,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",CLAGTTGGILWWYEGLPQQH,,81,100,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581706,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/73255,"Linear peptide",WWYEGLPQQHYIGLVAIGGR,"EV0 peptide 10",,,91,110,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,9,42.9,"The stimulation index of the protected group of ponies (n = 14) was higher than that of the group (n = 7) progressing to disease, but the difference was not significant.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",WWYEGLPQQHYIGLVAIGGR,,91,110,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581707,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/74218,"Linear peptide",YIGLVAIGGRLNGSGQSNAI,"EV0 peptide 11",,,101,120,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,2,9.5,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",YIGLVAIGGRLNGSGQSNAI,,101,120,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581708,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/11274,"Linear peptide",ECWGSFPGCRPFQNYFSYET,"EV0 peptide 13",,,121,140,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,1,4.8,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ECWGSFPGCRPFQNYFSYET,,121,140,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581716,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/45737,"Linear peptide",NRSMHMDNNTATLLEAYHRE,"EV0 peptide 15",,,141,160,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,7,33.3,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",NRSMHMDNNTATLLEAYHRE,,141,160,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581717,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/28895,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,"EV0 peptide 17",,,161,180,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,11,52.4,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,,161,180,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581720,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/31731,"Linear peptide",KKVNLNSSDSSNPVRVEDVM,"EV0 peptide 19",,,181,200,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,5,23.8,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KKVNLNSSDSSNPVRVEDVM,,181,200,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581721,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/59882,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EV0 peptide 20",,,191,210,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,,191,210,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581723,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/46279,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EV0 peptide 21",,,201,220,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",NTTEYWGFKWLECNQTENFK,,201,220,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581724,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/64372,"Linear peptide",TILVPENEMVNINDTDTWIP,"EV0 peptide 23",,,221,240,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,2,9.5,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",TILVPENEMVNINDTDTWIP,,221,240,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581725,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/30904,"Linear peptide",KGCNETWARVKRCPIDILYG,"EV0 peptide 25",,,241,260,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KGCNETWARVKRCPIDILYG,,241,260,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581726,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/26399,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EV0 peptide 27",,,261,280,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,5,23.8,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,,261,280,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581727,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/3430,"Linear peptide",ANTSRIGNCGPTIFLGVLED,"EV0 peptide 29",,,281,300,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ANTSRIGNCGPTIFLGVLED,,281,300,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581728,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/44499,"Linear peptide",NKGVVRGNYTACNVSRLKIN,"EV0 peptide 31",,,301,320,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,5,23.8,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",NKGVVRGNYTACNVSRLKIN,,301,320,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581729,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/47900,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EV0 peptide 34",,,331,350,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,8,38.1,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",PIFYTCNFTNITSCNNEPII,,331,350,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581751,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/29080,"Linear peptide",ITSCNNEPIISVIMYETNQV,"EV0 peptide 35",,,341,360,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,3,14.3,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",ITSCNNEPIISVIMYETNQV,,341,360,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581752,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/45290,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EV0 peptide 38",,,371,390,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,9,42.9,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,,371,390,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581753,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/57858,"Linear peptide",SFNQYNCSINNKTELETWKL,"EV0 peptide 41",,,401,420,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,2,9.5,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",SFNQYNCSINNKTELETWKL,,401,420,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1581754,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/69326,"Linear peptide",VKTSGITPLPISSEANTGLI,"EV0 peptide 43",,,421,440,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,5,23.8,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",VKTSGITPLPISSEANTGLI,,421,440,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582216,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/55427,"Linear peptide",RQIKILYAMILQTHADVQLL,"EV0 peptide 51",,,501,520,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,9,42.9,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",RQIKILYAMILQTHADVQLL,,501,520,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582218,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/30593,"Linear peptide",KERQQVEETFNLIGCIERTH,"EV0 peptide 53",,,521,540,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,6,28.6,"The stimulation index of the protected group of ponies (n = 14) was higher than that of the group (n = 7) progressing to disease, but the difference was not significant. One of 7 of the group progressing to disease responded versus 5 of 14 of the protected group.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KERQQVEETFNLIGCIERTH,,521,540,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582219,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/42715,"Linear peptide",MSWGHLNESTQWDDWVSKME,"EV0 peptide 56",,,551,570,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,10,47.6,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",MSWGHLNESTQWDDWVSKME,,551,570,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582220,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/41781,"Linear peptide",MITFNTPDSIAQFGKDLWSH,"EV0 peptide 60",,,591,610,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",MITFNTPDSIAQFGKDLWSH,,591,610,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582222,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/3960,"Linear peptide",AQFGKDLWSHIGNWIPGLGA,"EV0 peptide 61",,,601,620,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,17,81,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",AQFGKDLWSHIGNWIPGLGA,,601,620,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582223,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/57970,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,"EV0 peptide 66",,,651,670,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,3,14.3,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",SGAGSSGSRYLKKKFHHKHA,,651,670,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582224,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/60644,"Linear peptide",SREDTWDQAQHNIHLAGVTG,"EV0 peptide 68",,,671,690,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",SREDTWDQAQHNIHLAGVTG,,671,690,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582225,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/22334,"Linear peptide",GSGDKYYKQKCSRNDWNGES,"EV0 peptide 70",,,691,710,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,5,23.8,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",GSGDKYYKQKCSRNDWNGES,,691,710,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582246,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/74370,"Linear peptide",YISEKTKGEISQPGAAINEH,"EV0 peptide 74",,,731,750,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,3,14.3,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",YISEKTKGEISQPGAAINEH,,731,750,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582247,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/50958,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,"EV0 peptide 77",,,761,780,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",QGSLDLEIRSEGGNIYDCCI,,761,780,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582248,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/29919,"Linear peptide",KAQEGTLAIPCCGFPLWLFW,"EV0 peptide 79",,,781,800,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive,,,21,4,19,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",KAQEGTLAIPCCGFPLWLFW,,781,800,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582259,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/21197,"Linear peptide",GLVIIVGRIAGYGLRGLAVI,"EV0 peptide 81",,,801,820,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 2 and 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,21,0,0,"There was no significant difference in the stimulation index between the protected group of ponies (n = 14) versus the group (n = 7) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class II",http://purl.obolibrary.org/obo/MRO_0001757,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",GLVIIVGRIAGYGLRGLAVI,,801,820,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582310,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/10156,"Linear peptide",DSKNSMAESKEARDQEMNLK,"EV0 peptide 5",,,41,60,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",DSKNSMAESKEARDQEMNLK,,41,60,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,4,33.3,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of  the group (n = 5) progressing to disease. None of the latter group showed an epitope-specific CTL response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DSKNSMAESKEARDQEMNLK,,41,60,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582311,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/6537,"Linear peptide",CLAGTTGGILWWYEGLPQQH,"EV0 peptide 9",,,81,100,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",CLAGTTGGILWWYEGLPQQH,,81,100,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,7,58.3,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of  the group (n = 5) progressing to disease. None of the latter group showed an epitope-specific CTL response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",CLAGTTGGILWWYEGLPQQH,,81,100,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582312,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/28895,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,"EV0 peptide 17",,,161,180,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,,161,180,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,7,58.3,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of  the group (n = 5) progressing to disease. None of the latter group showed an epitope-specific CTL response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ITFIYKSSCTDSDHCQEYQC,,161,180,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582313,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/59882,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EV0 peptide 20",,,191,210,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,,191,210,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,8,66.7,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of the group (n = 5) progressing to disease. All of the protected group showed an epitope-specific CTL response, whereas in the non-protected group 1 of 5 responded.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,,191,210,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582314,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/46279,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EV0 peptide 21",,,201,220,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years","ELA-A9 class I;ELA-W11 class I;ELA-A1 class I;ELA-A3 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NTTEYWGFKWLECNQTENFK,,201,220,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,7,58.3,"The cytolytic activity of the protected group of ponies (n = 7) was higher than that of  the group (n = 5) progressing to disease, but the difference was not significant.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NTTEYWGFKWLECNQTENFK,,201,220,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582315,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/64372,"Linear peptide",TILVPENEMVNINDTDTWIP,"EV0 peptide 23",,,221,240,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",TILVPENEMVNINDTDTWIP,,221,240,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,4,33.3,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",TILVPENEMVNINDTDTWIP,,221,240,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582317,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/26399,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EV0 peptide 27",,,261,280,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,,261,280,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,10,83.3,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,,261,280,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582318,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/47900,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EV0 peptide 34",,,331,350,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",PIFYTCNFTNITSCNNEPII,,331,350,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,4,33.3,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",PIFYTCNFTNITSCNNEPII,,331,350,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582319,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/45290,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EV0 peptide 38",,,371,390,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,,371,390,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,6,50,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of  the group (n = 5) progressing to disease. Five of 7 in the protected group responded, whereas 1 of 5 in the non-protected group showed an epitope-specific CTL response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,,371,390,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582320,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/74370,"Linear peptide",YISEKTKGEISQPGAAINEH,"EV0 peptide 74",,,731,750,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"The epitope sequence is from the reference cited: Tagmyer et al. (2007) J Gen Virol 88: 1324-1336 [PMID: 17374779].",,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",YISEKTKGEISQPGAAINEH,,731,750,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,5,41.7,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",YISEKTKGEISQPGAAINEH,,731,750,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582322,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/10836,"Linear peptide",DWWKIGMFLLCLAGTTGGIL,"EV0 peptide 8",,,71,90,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",DWWKIGMFLLCLAGTTGGIL,,71,90,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,6,50,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of  the group (n = 5) progressing to disease. None of the latter group showed an epitope-specific CTL response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DWWKIGMFLLCLAGTTGGIL,,71,90,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582323,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/10092,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,"EV0 peptide 18",,,171,190,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years","ELA-W11 class I;ELA-A1 class I;ELA-A3 class I;ELA-A9 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,,171,190,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,6,50,"The cytolytic activity of the protected group of ponies (n = 7) was higher than that of  the group (n = 5) progressing to disease, but the difference was not significant.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,,171,190,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582324,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/44295,"Linear peptide",NINDTDTWIPKGCNETWARV,"EV0 peptide 24",,,231,250,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NINDTDTWIPKGCNETWARV,,231,250,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,5,41.7,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of  the group (n = 5) progressing to disease. None of the latter group showed an epitope-specific CTL response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",NINDTDTWIPKGCNETWARV,,231,250,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582325,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/33114,"Linear peptide",KRCPIDILYGIHPIRLCVQP,"EV0 peptide 26",,,251,270,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",KRCPIDILYGIHPIRLCVQP,,251,270,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,5,41.7,"The cytolytic activity of the protected group of ponies (n = 7) was significantly higher than that of  the group (n = 5) progressing to disease. None of the latter group showed an epitope-specific CTL response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",KRCPIDILYGIHPIRLCVQP,,251,270,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582326,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/583,"Linear peptide",ACNVSRLKINRKDYTGIYQV,"EV0 peptide 32",,,311,330,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",ACNVSRLKINRKDYTGIYQV,,311,330,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,10,83.3,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",ACNVSRLKINRKDYTGIYQV,,311,330,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582327,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/54336,"Linear peptide",RKDYTGIYQVPIFYTCNFTN,"EV0 peptide 33",,,321,340,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RKDYTGIYQVPIFYTCNFTN,,321,340,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,4,33.3,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",RKDYTGIYQVPIFYTCNFTN,,321,340,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582328,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/62168,"Linear peptide",SVIMYETNQVQYLLCNNNNS,"EV0 peptide 36",,,351,370,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",SVIMYETNQVQYLLCNNNNS,,351,370,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,7,58.3,"The cytolytic activity of the protected group of ponies (n = 7) was higher than that of the group (n = 5) progressing to disease, but the difference was not significant.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",SVIMYETNQVQYLLCNNNNS,,351,370,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582329,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/38998,"Linear peptide",LQTHADVQLLKERQQVEETF,"EV0 peptide 52",,,511,530,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",LQTHADVQLLKERQQVEETF,,511,530,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,9,75,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",LQTHADVQLLKERQQVEETF,,511,530,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582330,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/26290,"Linear peptide",IGNWIPGLGASIIKYIVMFL,"EV0 peptide 62",,,611,630,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IGNWIPGLGASIIKYIVMFL,,611,630,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,10,83.3,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",IGNWIPGLGASIIKYIVMFL,,611,630,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582331,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/11938,"Linear peptide",EEYNRRPKSWVKSIEAFGES,"EV0 peptide 72",,,711,730,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",EEYNRRPKSWVKSIEAFGES,,711,730,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,12,5,41.7,"There was no significant difference in the cytolytic activity between the protected group of ponies (n = 7) versus the group (n = 5) progressing to disease.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,Epitope,"Linear peptide",EEYNRRPKSWVKSIEAFGES,,711,730,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582509,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/10092,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,"EV0 peptide 18",,,171,190,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years","ELA-W11 class I;ELA-A1 class I;ELA-A3 class I;ELA-A9 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,,171,190,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",DSDHCQEYQCNKVNLNLNSF,"EV6 peptide 18",47,66,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582510,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/10092,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,"EV0 peptide 18",,,171,190,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years","ELA-W11 class I;ELA-A1 class I;ELA-A3 class I;ELA-A9 class I","Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",DSDHCQEYQCKKVNLNSSDS,,171,190,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",DSDHCQEYQCKKVNFTVSKA,"EV13 peptide 18",11,30,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582511,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/59882,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EV0 peptide 20",,,191,210,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,,191,210,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",DSSIHVEDVKDTTEYWGFKW,"EV6 peptide 20",67,86,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582512,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/59882,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,"EV0 peptide 20",,,191,210,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",SNPVRVEDVMNTTEYWGFKW,,191,210,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",NGSSIPSIHVGGVEDAETTIEYWGFKW,"EV13 peptide 20",31,57,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582513,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/46279,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EV0 peptide 21",,,201,220,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NTTEYWGFKWLECNQTENFK,,201,220,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",DTTEYWGFKWLECNQTENFK,"EV6 peptide 21",77,96,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582514,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/46279,"Linear peptide",NTTEYWGFKWLECNQTENFK,"EV0 peptide 21",,,201,220,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NTTEYWGFKWLECNQTENFK,,201,220,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",TTIEYWGFKWLECNQTENLK,"EV13 peptide 21",48,67,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582515,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/26399,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EV0 peptide 27",,,261,280,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,,261,280,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",IHPIRLCVQPPFFLVQEKEV,"EV6 peptide 27",137,156,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582516,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/26399,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,"EV0 peptide 27",,,261,280,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IHPIRLCVQPPFFLVQEKGI,,261,280,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",IHPIRLCVQPPFFLVQENRG,"EV13 peptide 27",107,126,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582517,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/47900,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EV0 peptide 34",,,331,350,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",PIFYTCNFTNITSCNNEPII,,331,350,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",PIFYTCNFTNITSCNNESII,"EV6 peptide 34",207,226,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582518,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/47900,"Linear peptide",PIFYTCNFTNITSCNNEPII,"EV0 peptide 34",,,331,350,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",PIFYTCNFTNITSCNNEPII,,331,350,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",PMFYTCNFTSITSCNDESIT,"EV13 peptide 34",177,196,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582519,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/45290,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EV0 peptide 38",,,371,390,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,,371,390,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",NHYNCVVQSFGVIGQAHLEL,"EV6 peptide 38",247,266,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582521,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/44295,"Linear peptide",NINDTDTWIPKGCNETWARV,"EV0 peptide 24",,,231,250,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NINDTDTWIPKGCNETWARV,,231,250,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",NINDNDTWIAKGCNETWARV,"EV6 peptide 24",107,126,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582522,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/44295,"Linear peptide",NINDTDTWIPKGCNETWARV,"EV0 peptide 24",,,231,250,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NINDTDTWIPKGCNETWARV,,231,250,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",KIKNGTWTPKGCNETWARV,"EV13 peptide 24",78,96,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582523,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/583,"Linear peptide",ACNVSRLKINRKDYTGIYQV,"EV0 peptide 32",,,311,330,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",ACNVSRLKINRKDYTGIYQV,,311,330,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",ACNVSHLRINRKDYTGIYQV,"EV6 peptide 32",187,206,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582524,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/583,"Linear peptide",ACNVSRLKINRKDYTGIYQV,"EV0 peptide 32",,,311,330,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",ACNVSRLKINRKDYTGIYQV,,311,330,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",ACNVRKLGINRKDYTGIYQG,"EV13 peptide 32",157,176,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582526,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/62168,"Linear peptide",SVIMYETNQVQYLLCNNNNS,"EV0 peptide 36",,,351,370,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",SVIMYETNQVQYLLCNNNNS,,351,370,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",SVIMYETNQVQYLLCKYNTT,"EV13 peptide 36",198,217,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51085.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582527,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/45290,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,"EV0 peptide 38",,,371,390,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",NNYNCVVQSFGVIGQAHLEL,,371,390,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",DSNYTCVVQSFGVIGQAHLEL,"EV13 peptide 38",217,237,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582528,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/64372,"Linear peptide",TILVPENEMVNINDTDTWIP,"EV0 peptide 23",,,221,240,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",TILVPENEMVNINDTDTWIP,,221,240,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",TILVPENEMVNINDNDTWIA,"EV6 peptide 23",97,116,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAK51293.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1582529,http://www.iedb.org/reference/1009527,Literature,18234792,,"Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro","J Virol",2008,"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.",http://www.iedb.org/epitope/64372,"Linear peptide",TILVPENEMVNINDTDTWIP,"EV0 peptide 23",,,221,240,,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,"Equus caballus (domestic horse)",http://purl.obolibrary.org/obo/NCBITaxon_9796,,,,"3-12 years",,"Administration in vivo",,,,"Source Organism",Organism,"Equine infectious anemia virus (equine infectious anemia virus EIAV)","Attenuated EIAVD9 [vaccine]",,,,,,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",TILVPENEMVNINDTDTWIP,,221,240,,Env,http://www.ncbi.nlm.nih.gov/protein/AAC03762.1,"Envelope glycoprotein",http://www.uniprot.org/uniprot/P32541,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,N,,"At 7 months post-vaccination, ponies were challenged with 10^3 median tissue culture infectious doses of EV0, EV6, or EV13. The EV0 Env gp90 is homologous to that in the EIAVD9 vaccine strain; the EV6 and EV13 gp90 protein sequences differ from EV0 by 6% and 13%, respectively. PBMC were obtained from the ponies on the day of challenge.","Figure 6","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo","ELA class I",http://purl.obolibrary.org/obo/MRO_0001448,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,I,"Taxonomic Sibling","Linear peptide",TILVPENEMVKIKNGTWTP,"EV13 peptide 23",68,86,,"envelope protein gp90",http://www.ncbi.nlm.nih.gov/protein/AAW51083.1,,,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665,"Equine infectious anemia virus",http://purl.obolibrary.org/obo/NCBITaxon_11665
http://www.iedb.org/assay/1583966,http://www.iedb.org/reference/1013424,Literature,8057464,,"J N Flynn; C A Cannon; J A Beatty; M Mackett; M A Rigby; J C Neil; C Jarrett","J Virol",1994,"Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.",http://www.iedb.org/epitope/94789,"Linear peptide",CAADKEILDE,"10-residue FIV peptide 2 (FIV gag 196-205)",,,196,205,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus (strain UK8)",http://purl.obolibrary.org/obo/NCBITaxon_36372,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,Adult,,"Administration in vivo",,,,"Structurally Related","Linear peptide",CAADKEILDESLKWKQR,"17-residue FIV peptide 1 (gag 196-208, env 395-398)",,,,,,,,,,,,;QS-21;,subcutaneous,"2 doses of 50ug peptide 1, followed by 2 doses of 100ug of same antigen administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Structurally Related","Linear peptide",CAADKEILDESLKWKQR,,,,,,,,,,,,,N,,"Cats were immunized with 50ug of peptide on two occasions, followed by a further two immunizations of 100ug in with 50ug Quil A in 1ml of sterile saline.","Figure 3",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,4,0,0,"PBMCs from cats immunized with peptide 1, which consists of a synthetic conjugate of gag (196-208) and env (395-398), failed to proliferate in response to the constituent 10-mer peptide 2.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated","H2 class II",http://purl.obolibrary.org/obo/MRO_0001461,"T cell assay -Biological process measured",http://purl.obolibrary.org/obo/ECO_0008083,II,Epitope,"Linear peptide",CAADKEILDE,"10-residue FIV peptide 2 (FIV gag 196-205)",196,205,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus (strain UK8)",http://purl.obolibrary.org/obo/NCBITaxon_36372,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/1583968,http://www.iedb.org/reference/1013424,Literature,8057464,,"J N Flynn; C A Cannon; J A Beatty; M Mackett; M A Rigby; J C Neil; C Jarrett","J Virol",1994,"Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.",http://www.iedb.org/epitope/94789,"Linear peptide",CAADKEILDE,"10-residue FIV peptide 2 (FIV gag 196-205)",,,196,205,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus (strain UK8)",http://purl.obolibrary.org/obo/NCBITaxon_36372,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,Adult,,"Administration in vivo",,,,"Structurally Related","Linear peptide",CAADKEILDESLKWKQR,"17-residue FIV peptide 1 (gag 196-208, env 395-398)",,,,,,,,,,,,;QS-21;,subcutaneous,"2 doses of 50ug peptide 1, followed by 2 doses of 100ug of same antigen administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Cats were immunized with 50ug of peptide on two occasions, followed by a further two immunizations of 100ug in with 50ug Quil A in 1ml of sterile saline.","Figure 4, 5 and 7","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,4,3,75,"Fresh PBMCs from cats immunized with peptide 1, which consists of a synthetic conjugate of gag (196-208) and env (395-398), recognized and lysed targets pulsed with the constituent 10-mer peptide 2. In vitro restimulation with the epitope increased the level of specific lysis.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Cell Line / Clone","H2 class I",http://purl.obolibrary.org/obo/MRO_0001460,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,I,Epitope,"Linear peptide",CAADKEILDE,"10-residue FIV peptide 2 (FIV gag 196-205)",196,205,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus (strain UK8)",http://purl.obolibrary.org/obo/NCBITaxon_36372,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/1583971,http://www.iedb.org/reference/1013424,Literature,8057464,,"J N Flynn; C A Cannon; J A Beatty; M Mackett; M A Rigby; J C Neil; C Jarrett","J Virol",1994,"Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.",http://www.iedb.org/epitope/94789,"Linear peptide",CAADKEILDE,"10-residue FIV peptide 2 (FIV gag 196-205)",,,196,205,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus (strain UK8)",http://purl.obolibrary.org/obo/NCBITaxon_36372,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673,,,,,,,,,,,,,,,,,"Felis catus (cat)",http://purl.obolibrary.org/obo/NCBITaxon_9685,,,,Adult,,"Administration in vivo",,,,"Structurally Related","Linear peptide",CAADKEILDESLKWKQR,"17-residue FIV peptide 1 (gag 196-208, env 395-398)",,,,,,,,,,,,;QS-21;,subcutaneous,"2 doses of 50ug peptide 1, followed by 2 doses of 100ug of same antigen administered at intervals of 3 weeks.",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Structurally Related","Linear peptide",CAADKEILDESLKWKQR,,,,,,,,,,,,,N,,"Cats were immunized with 50ug of peptide on two occasions, followed by a further two immunizations of 100ug in with 50ug Quil A in 1ml of sterile saline.","Figure 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive,,,2,2,100,"PBMCs from cats immunized with peptide 1, which consists of a synthetic conjugate of gag (196-208) and env (395-398), recognized and lysed targets pulsed with the constituent 10-mer peptide 2. In vitro restimulation with the epitope increased the level of specific lysis.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Cell Line / Clone","H2 class I",http://purl.obolibrary.org/obo/MRO_0001460,"T cell assay -T cell subset identification",http://purl.obolibrary.org/obo/ECO_0008086,I,Epitope,"Linear peptide",CAADKEILDE,"10-residue FIV peptide 2 (FIV gag 196-205)",196,205,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P31821.1,"Gag polyprotein",http://www.uniprot.org/uniprot/P16087,"Feline immunodeficiency virus (strain UK8)",http://purl.obolibrary.org/obo/NCBITaxon_36372,"Feline immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11673
http://www.iedb.org/assay/1603601,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/99957,"Linear peptide",DSRYAFEFMIRN,P2.1,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive-High,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",DSRYAFEFMIRN,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1603607,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/100489,"Linear peptide",RYAFEFMIRNWD,P2.2,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive-Low,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",RYAFEFMIRNWD,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1603608,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/99880,"Linear peptide",AFEFMIRNWDEE,P2.3,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Negative,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",AFEFMIRNWDEE,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1603609,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/99984,"Linear peptide",EFMIRNWDEEVI,P2.4,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive-Low,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",EFMIRNWDEEVI,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1603610,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/100305,"Linear peptide",MIRNWDEEVIKN,P2.5,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive-High,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",MIRNWDEEVIKN,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1603611,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/100480,"Linear peptide",RNWDEEVIKNPI,P2.6,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive-Low,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",RNWDEEVIKNPI,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1603612,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/100640,"Linear peptide",WDEEVIKNPIQA,P2.7,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figure 4","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive-High,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",WDEEVIKNPIQA,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1603613,http://www.iedb.org/reference/1013732,Literature,18796728,,"Changxin Wu; Cyril Barbezange; Ian McConnell; Barbara A Blacklaws","J Gen Virol",2008,"Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.",http://www.iedb.org/epitope/99932,"Linear peptide",DEEVIKNPIQAR,P2.8,,,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,,,,,,,,,,,,,,,,"Ovis aries (domestic sheep)",http://purl.obolibrary.org/obo/NCBITaxon_9940,,,,adult,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Visna/maedi virus EV1 (Maedi-Visna-like virus EV1)",,,,,,,,,"Visna/maedi virus EV1",http://purl.obolibrary.org/obo/NCBITaxon_12750,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,,subcutaneous,"1 dose of 105 TCID50 >3 months before assay",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Fibroblast,http://purl.obolibrary.org/obo/CL_0000057,"Source Organism",Organism,"Visna-maedi virus (Maedi visna virus)",,,,,,,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,N,,,"Figures 4 and 5","51 chromium",cytotoxicity,,http://purl.obolibrary.org/obo/OBI_1110150,Positive-High,,,,,,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Skin,http://purl.obolibrary.org/obo/UBERON_0002097,Unknown/Unspecified,http://purl.obolibrary.org/obo/GO_0005623,"Cell Line / Clone","Ovar class I",http://purl.obolibrary.org/obo/MRO_0001853,"T cell assay -MHC subset identification",http://purl.obolibrary.org/obo/ECO_0008084,I,Epitope,"Linear peptide",DEEVIKNPIQAR,,,,,"pol polyprotein",https://ontology.iedb.org/ontology/ONTIE_0002782,,,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971,"Visna-maedi virus",http://purl.obolibrary.org/obo/NCBITaxon_2169971
http://www.iedb.org/assay/1646918,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/108026,"Linear peptide",LYCKMNWFL,NAT-7,,,403,411,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACQ89795.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD.Cg-Tg",https://ontology.iedb.org/ontology/ONTIE_0001063,,,,"6 to 8 weeks old",,"Occurrence of autoimmune disease","prediabetes syndrome",http://purl.obolibrary.org/obo/DOID_11716,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice used in this assay were 8.3-NOD.RAG-2-/-.","Figure 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Negative,,,,,,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",LYCKMNWFL,,403,411,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACQ89795.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1646934,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/107841,"Linear peptide",FYCKMNWFL,NAT-23,,,161,169,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD.Cg-Tg",https://ontology.iedb.org/ontology/ONTIE_0001063,,,,"6 to 8 weeks old",,"Occurrence of autoimmune disease","prediabetes syndrome",http://purl.obolibrary.org/obo/DOID_11716,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice used in this assay were 8.3-NOD.RAG-2-/-.","Figure 4",3H-thymidine,proliferation,,http://purl.obolibrary.org/obo/OBI_1110180,Positive-Low,,,,,,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",FYCKMNWFL,,161,169,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1646978,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/108026,"Linear peptide",LYCKMNWFL,NAT-7,,,403,411,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACQ89795.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD.Cg-Tg",https://ontology.iedb.org/ontology/ONTIE_0001063,,,,"6 to 8 weeks old",,"Occurrence of autoimmune disease","prediabetes syndrome",http://purl.obolibrary.org/obo/DOID_11716,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice used in this assay were 8.3-NOD.RAG-2-/-.","Figure 4",ELISA,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110151,Negative,,,,,,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",LYCKMNWFL,,403,411,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACQ89795.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1646994,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/107841,"Linear peptide",FYCKMNWFL,NAT-23,,,161,169,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD.Cg-Tg",https://ontology.iedb.org/ontology/ONTIE_0001063,,,,"6 to 8 weeks old",,"Occurrence of autoimmune disease","prediabetes syndrome",http://purl.obolibrary.org/obo/DOID_11716,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice used in this assay were 8.3-NOD.RAG-2-/-.","Figure 4",ELISA,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110151,Positive-Low,,,,,,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",FYCKMNWFL,,161,169,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1647042,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/107841,"Linear peptide",FYCKMNWFL,NAT-23,,,161,169,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD.Cg-Tg",https://ontology.iedb.org/ontology/ONTIE_0001063,,,,"6 to 8 weeks old",,"Occurrence of autoimmune disease","prediabetes syndrome",http://purl.obolibrary.org/obo/DOID_11716,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Primary induction in vitro","T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Structurally Related","Linear peptide",KYNKANWFL,,,,,,,,,,,,,N,,"Mice used in this assay were 8.3-NOD.RAG-2-/-.","Figures 5 and 6",ELISA,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110151,Positive-Intermediate,,,,,,"Similar results were seen with splenic CD8+ T cells as effector cells.",Pancreas,http://purl.obolibrary.org/obo/UBERON_0001264,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Short Term Restimulated",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",FYCKMNWFL,,161,169,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1647079,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/107841,"Linear peptide",FYCKMNWFL,NAT-23,,,161,169,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD",https://ontology.iedb.org/ontology/ONTIE_0000540,,,,"20 weeks old",,"Occurrence of autoimmune disease","type 1 diabetes mellitus",http://purl.obolibrary.org/obo/DOID_9744,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Primary induction in vitro","T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Structurally Related","Linear peptide",KYNKANWFL,,,,,,,,,,,,,N,,,"Figures 7 and 9",ELISA,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110151,Positive,,,,,,"Results were similar in 9 week old mice. After sorting effector cells by binding to Kd tetramers, the tetramer-negative cells from 9- or 20-week-old mice did not mount significant responses to eptiope.",Pancreas,http://purl.obolibrary.org/obo/UBERON_0001264,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Short Term Restimulated",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",FYCKMNWFL,,161,169,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1647946,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/107841,"Linear peptide",FYCKMNWFL,NAT-23,,,161,169,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD.Cg-Tg",https://ontology.iedb.org/ontology/ONTIE_0001063,,,,"6 to 8 weeks old",,"Occurrence of autoimmune disease","prediabetes syndrome",http://purl.obolibrary.org/obo/DOID_11716,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Primary induction in vitro","T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Structurally Related","Linear peptide",KYNKANWFL,,,,,,,,,,,,,N,,"Mice used in this assay were 8.3-NOD.RAG-2-/-.","Figure 5",ELISA,"IL-2 release",,http://purl.obolibrary.org/obo/OBI_1110152,Negative,,,,,,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Short Term Restimulated",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",FYCKMNWFL,,161,169,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/1647969,http://www.iedb.org/reference/1014778,Literature,11441068,,"A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria","J Immunol",2001,"Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.",http://www.iedb.org/epitope/107841,"Linear peptide",FYCKMNWFL,NAT-23,,,161,169,,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus NOD.Cg-Tg",https://ontology.iedb.org/ontology/ONTIE_0001063,,,,"6 to 8 weeks old",,"Occurrence of autoimmune disease","prediabetes syndrome",http://purl.obolibrary.org/obo/DOID_11716,"Acute/Recent onset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice used in this assay were 8.3-NOD.RAG-2-/-.","Figure 5",ELISA,"IL-2 release",,http://purl.obolibrary.org/obo/OBI_1110152,Negative,,,,,,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,Spleen,http://purl.obolibrary.org/obo/UBERON_0002106,Splenocyte,http://purl.obolibrary.org/obo/CL_2000074,"Direct Ex Vivo",H2-Kd,http://purl.obolibrary.org/obo/MRO_0000992,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide",FYCKMNWFL,,161,169,,"envelope glycoprotein",http://www.ncbi.nlm.nih.gov/protein/ACT68561.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/2096378,http://www.iedb.org/reference/1027374,Literature,24068737,,"Adrienne V Li; James J Moon; Wuhbet Abraham; Heikyung Suh; Jamal Elkhader; Michael A Seidman; Minmin Yen; Eung-Jun Im; Maria H Foley; Dan H Barouch; Darrell J Irvine","Sci Transl Med",2013,"Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination.",http://www.iedb.org/epitope/226820,"Linear peptide",AAVKNWMTQTL,"AL11 peptide",,,312,322,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,"6-10 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",AAVKNWMTQTL,,312,322,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intratracheal,"2 doses of 10 ug AL11 on days 0 and 28",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with interbilayer-crosslinked multilamellar vesicles (ICMVs) coated with the epitope.  MPLA and poly I:C were used as adjuvants.","Figures 4, 5, S6 and S7",multimer/tetramer,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_1110179,Positive,,,,,,"Cells from blood and lungs showed a positive response.  Mice immunized with ICMVs showed a stronger response than mice immunized with the soluble peptide alone.",Lung,http://purl.obolibrary.org/obo/UBERON_0002048,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,,,,,,H2-Db,http://purl.obolibrary.org/obo/MRO_0000966,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",AAVKNWMTQTL,,312,322,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/2096385,http://www.iedb.org/reference/1027374,Literature,24068737,,"Adrienne V Li; James J Moon; Wuhbet Abraham; Heikyung Suh; Jamal Elkhader; Michael A Seidman; Minmin Yen; Eung-Jun Im; Maria H Foley; Dan H Barouch; Darrell J Irvine","Sci Transl Med",2013,"Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination.",http://www.iedb.org/epitope/226820,"Linear peptide",AAVKNWMTQTL,"AL11 peptide",,,312,322,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,F,"6-10 weeks",,"Administration in vivo",,,,Epitope,"Linear peptide",AAVKNWMTQTL,,312,322,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intratracheal,"2 doses of 10 ug AL11 on days 0 and 28",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Mice were immunized with interbilayer-crosslinked multilamellar vesicles (ICMVs) coated with the epitope.  MPLA and poly I:C were used as adjuvants.","Figure 4","in vivo assay","pathogen burden after challenge",,http://purl.obolibrary.org/obo/OBI_0001475,Positive,,,,,,"The epitope protected mice from SIV gag-expressing vaccinia virus infection.",,,,,,,,,,,,,H2-Db,http://purl.obolibrary.org/obo/MRO_0000966,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,"Source Antigen",Protein,"gag polyprotein",,,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/2621258,http://www.iedb.org/reference/1029828,Literature,26758274,,"Daisuke Morita; Yukie Yamamoto; Tatsuaki Mizutani; Takeshi Ishikawa; Juri Suzuki; Tatsuhiko Igarashi; Naoki Mori; Takashi Shiina; Hidetoshi Inoko; Hiroaki Fujita; Kazuhiro Iwai; Yoshimasa Tanaka; Bunzo Mikami; Masahiko Sugita","Nat Commun",2016,"Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex.",http://www.iedb.org/epitope/547461,"Linear peptide","GGAIS + MYRI(G1)","C14nef5 (N-myristoylated Nef peptide)",G1,Myristoylation|MYRI,2,6,,,"Protein Nef",http://www.ncbi.nlm.nih.gov/protein/P12482.4,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Primary induction in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide","GGAIS + MYRI(G1)",,2,6,,"Protein Nef",http://www.ncbi.nlm.nih.gov/protein/P12482.4,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Generation of the T Cell clone 2N5.1 was previously described in the cited reference: Morita et al. (2011) J Immunol 187: 608-612 [PMID: 21653836]. PBMCs, obtained from rhesus macaque monkeys, were cultured with the epitope, and antigenic stimulation was repeated every 2 wk in the presence of irradiated autologous PBMCs and IL-2.","Figure 1 and Supplementary Figure 1",ELISA,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110151,Positive,,,,,,"The monkey kidney epithelial cell line LLC-MK2, transfected with Mamu-B*098, stimulated 2N5.1 cells to produce interferon-γ (IFN-γ) in the presence of the epitope C14nef5. LLC-MK2 cells transfected with other Mamu class I MHC alleles did not present the epitope and stimulate IFN-γ production. Plate-bound Mamu-B*098 was also able to present epitope and stimulate IFN-γ production. Authors refer to the MHC molecule as Mamu-B*098. This may mean  Mamu-B*098:01:01, Mamu-B*098:01:02, Mamu-B*098:02, Mamu-B*098:03, or Mamu-B*098:04.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell",http://purl.obolibrary.org/obo/CL_0000084,"Cell Line / Clone",2N5.1,,Kidney,http://purl.obolibrary.org/obo/UBERON_0002113,"Epithelial cell",http://purl.obolibrary.org/obo/CL_0000066,"Cell Line / Clone","Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide","GGAIS + MYRI(G1)",,2,6,,"Protein Nef",http://www.ncbi.nlm.nih.gov/protein/P12482.4,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/2621259,http://www.iedb.org/reference/1029828,Literature,26758274,,"Daisuke Morita; Yukie Yamamoto; Tatsuaki Mizutani; Takeshi Ishikawa; Juri Suzuki; Tatsuhiko Igarashi; Naoki Mori; Takashi Shiina; Hidetoshi Inoko; Hiroaki Fujita; Kazuhiro Iwai; Yoshimasa Tanaka; Bunzo Mikami; Masahiko Sugita","Nat Commun",2016,"Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex.",http://www.iedb.org/epitope/547461,"Linear peptide","GGAIS + MYRI(G1)","C14nef5 (N-myristoylated Nef peptide)",G1,Myristoylation|MYRI,2,6,,,"Protein Nef",http://www.ncbi.nlm.nih.gov/protein/P12482.4,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"No immunization",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Primary induction in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide","GGAIS + MYRI(G1)",,2,6,,"Protein Nef",http://www.ncbi.nlm.nih.gov/protein/P12482.4,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Generation of the T Cell clone 2N5.1 was previously described in the cited reference: Morita et al. (2011) J Immunol 187: 608-612 [PMID: 21653836]. PBMCs, obtained from rhesus macaque monkeys, were cultured with the epitope, and antigenic stimulation was repeated every 2 wk in the presence of irradiated autologous PBMCs and IL-2. The 2N5.1 TCR was clones and expressed.","Figure 1d","surface plasmon resonance (SPR)","dissociation constant KD",nM,http://purl.obolibrary.org/obo/OBI_0001229,Positive,,2500,,,,"The affinity of the epitope-specific 2N5.1 TCR for the epitope-Mamu-B*098 complex was determined by surface plasmon resonance. Authors refer to the MHC molecule as Mamu-B*098. This may mean  Mamu-B*098:01:01, Mamu-B*098:01:02, Mamu-B*098:02, Mamu-B*098:03, or Mamu-B*098:04.",,,,,,2N5.1,,,,,,,"Mamu class I",http://purl.obolibrary.org/obo/MRO_0001466,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide","GGAIS + MYRI(G1)",,2,6,,"Protein Nef",http://www.ncbi.nlm.nih.gov/protein/P12482.4,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806676,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753304,"Linear peptide",AGTTSSVDEQIQWMY,"SIV Gag 237-251",,,237,251,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",AGTTSSVDEQIQWMY,,237,251,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,1,5.6,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",AGTTSSVDEQIQWMY,,237,251,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806678,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753308,"Linear peptide",APLVPTGSENLKSLY,"SIV Gag 65-79",,,65,79,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",APLVPTGSENLKSLY,,65,79,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,1,5.6,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",APLVPTGSENLKSLY,,65,79,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806681,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753327,"Linear peptide",CTPYDINQMLNCVGD,"SIV Gag 181-195",,,181,195,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",CTPYDINQMLNCVGD,,181,195,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,5,27.8,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",CTPYDINQMLNCVGD,,181,195,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806682,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753334,"Linear peptide",EEEVRRRLTARGLLN,"SIV Nef 241-255",,,241,255,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"nef protein [Simian immunodeficiency virus]","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",EEEVRRRLTARGLLN,,241,255,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,1,5.6,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",EEEVRRRLTARGLLN,,241,255,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806687,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753355,"Linear peptide",GLDKGLSSLSCEGQK,"SIV Nef 45-59",,,45,59,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"nef protein [Simian immunodeficiency virus]","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",GLDKGLSSLSCEGQK,,45,59,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,2,11.1,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",GLDKGLSSLSCEGQK,,45,59,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806690,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753373,"Linear peptide",IPDWQDYTSGPGIRY,"SIV Nef  153-167",,,153,167,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"nef protein [Simian immunodeficiency virus]","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",IPDWQDYTSGPGIRY,,153,167,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,1,5.6,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",IPDWQDYTSGPGIRY,,153,167,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806693,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753376,"Linear peptide",KCVRMYNPTNILDVK,"SIV Gag 273-287",,,273,287,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",KCVRMYNPTNILDVK,,273,287,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,2,11.1,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",KCVRMYNPTNILDVK,,273,287,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806694,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753389,"Linear peptide",LGLQKCVRMYNPTNI,"SIV Gag 269-283",,,269,283,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",LGLQKCVRMYNPTNI,,269,283,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,3,16.7,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",LGLQKCVRMYNPTNI,,269,283,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806697,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753393,"Linear peptide",LSEGCTPYDINQMLN,"SIV Gag 177-191",,,177,191,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",LSEGCTPYDINQMLN,,177,191,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,5,27.8,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",LSEGCTPYDINQMLN,,177,191,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806704,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753421,"Linear peptide",QGQLREPSGSDIAGT,"SIV Gag 225-239",,,225,239,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",QGQLREPSGSDIAGT,,225,239,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,2,11.1,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QGQLREPSGSDIAGT,,225,239,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806705,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753425,"Linear peptide",QSPGGLDKGLSSLSC,"SIV Nef 41-55",,,41,55,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"nef protein [Simian immunodeficiency virus]","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",QSPGGLDKGLSSLSC,,41,55,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,2,11.1,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",QSPGGLDKGLSSLSC,,41,55,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806708,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753429,"Linear peptide",RRHRILDIYLEKEEG,"SIV Nef 137-151",,,137,151,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"nef protein [Simian immunodeficiency virus]","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RRHRILDIYLEKEEG,,137,151,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,1,5.6,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",RRHRILDIYLEKEEG,,137,151,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806709,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753430,"Linear peptide",RRRLTARGLLNMADK,"SIV Nef 245-259",,,245,259,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"nef protein [Simian immunodeficiency virus]","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",RRRLTARGLLNMADK,,245,259,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,1,5.6,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",RRRLTARGLLNMADK,,245,259,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/3806711,http://www.iedb.org/reference/1032984,Submission,,1000759,"Mariel Mohns M.S.; Meghan Breitbach B.S.; Dawn Dudley Ph.D.; Matthew Reynolds Ph.D.; Jason Weinfurter M.S.; Justin Greene Ph.D.; Thomas Friedrich Ph.D.; Shelby O'Connor Ph.D.; David Price Ph.D.; David O'Connor Ph.D.",,2018,"Identifying common T cell responses to major pathogens in rhesus macaques",http://www.iedb.org/epitope/753442,"Linear peptide",SSVDEQIQWMYRQQN,"SIV Gag 241-255",,,241,255,,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Source Antigen",Protein,"gag polyprotein","rAd5 SIV",,,http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,intramuscular,"Prime injection of 10 billion viral particles with a boost injection of the same dose at 8 weeks",,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,Epitope,"Linear peptide",SSVDEQIQWMYRQQN,,241,255,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,,,ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,18,1,5.6,"Responses were identified by performing an ELISPOT using pooled overlapping 15mer peptides (10 peptides/pool), then a deconvolution of those pools to identify the specific 15mers eliciting the response.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Short Term Restimulated",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,,,,Epitope,"Linear peptide",SSVDEQIQWMYRQQN,,241,255,,"gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAA47632.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/5710552,http://www.iedb.org/reference/1035114,Literature,31043477,,"Yukie Yamamoto; Daisuke Morita; Yoko Shima; Akihiro Midorikawa; Tatsuaki Mizutani; Juri Suzuki; Naoki Mori; Takashi Shiina; Hidetoshi Inoko; Yoshimasa Tanaka; Bunzo Mikami; Masahiko Sugita","J Immunol",2019,"Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present -Myristoylated 4-mer Peptides to T Cells.",http://www.iedb.org/epitope/923338,"Linear peptide","GGAI + MYRI(G1)","C14nef4 (N-myristoylated 4-mer lipopeptide)",G1,Myristoylation|MYRI,2,5,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Simian immunodeficiency virus (Chimpanzee immunodeficiency virus)",,,,,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide","GGAIS + MYRI(G1)","C14-Gly-Gly-Ala-Ile-Ser (C14nef5)",2,6,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Generation of the T cell clone SN45 was previously described in the cited reference: Morita et al. (2013) J Virol 87: 482-488 [PMID: 23097434]. The C14-Gly-Gly-Ala-Ile-Ser (C14nef5)-specific T cell line, SN45, was obtained  from a SIV-infected monkey (MM521). Peripheral blood mononuclear cells (PBMCs) were cultured with C14-Gly-Gly-Ala-Ile-Ser (C14nef5) and antigenic stimulation was repeated every 2 weeks in the presence of irradiated autologous PBMCs. The SN45-derived TCR α and β cDNAs were cloned and transfected into TCRβ-deficient J.RT3 cells.","Figures 2 and 6",ELISA,"IL-2 release",,http://purl.obolibrary.org/obo/OBI_1110152,Positive,,,,,,"The J.RT3/SN45 TCR cell line produced IL-2 in response to the epitope presented by HeLa cells transfected with Mamu-B*05104. HeLa cells transfected with Mamu-B*06004 or Mamu-B11L*01 were not stimulatory. The J.RT3/SN45 TCR cell line did not produce IL-2 in response to HeLa-Mamu-B*05104 cells pulsed with the analog C14-GGGI.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,Engineered,SN45,,"Uterine Cervix",http://purl.obolibrary.org/obo/UBERON_0000002,"HeLa cells-Epithelial cell",http://purl.obolibrary.org/obo/CLO_0003684,"Cell Line / Clone",Mamu-B*051:04,http://purl.obolibrary.org/obo/MRO_0002141,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide","GGAI + MYRI(G1)",,2,5,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/5710553,http://www.iedb.org/reference/1035114,Literature,31043477,,"Yukie Yamamoto; Daisuke Morita; Yoko Shima; Akihiro Midorikawa; Tatsuaki Mizutani; Juri Suzuki; Naoki Mori; Takashi Shiina; Hidetoshi Inoko; Yoshimasa Tanaka; Bunzo Mikami; Masahiko Sugita","J Immunol",2019,"Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present -Myristoylated 4-mer Peptides to T Cells.",http://www.iedb.org/epitope/923338,"Linear peptide","GGAI + MYRI(G1)","C14nef4 (N-myristoylated 4-mer lipopeptide)",G1,Myristoylation|MYRI,2,5,,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Occurrence of infectious disease","viral infectious disease",http://purl.obolibrary.org/obo/DOID_934,"Acute/Recent onset","Source Organism",Organism,"Simian immunodeficiency virus (Chimpanzee immunodeficiency virus)",,,,,,,,,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Fragment of Source Antigen","Linear peptide","GGAIS + MYRI(G1)","C14-Gly-Gly-Ala-Ile-Ser (C14nef5)",2,6,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Generation of the T cell clone SN45 was previously described in the cited reference: Morita et al. (2013) J Virol 87: 482-488 [PMID: 23097434]. The C14-Gly-Gly-Ala-Ile-Ser (C14nef5)-specific T cell line, SN45, was obtained  from a SIV-infected monkey (MM521). Peripheral blood mononuclear cells (PBMCs) were cultured with C14-Gly-Gly-Ala-Ile-Ser (C14nef5) and antigenic stimulation was repeated every 2 weeks in the presence of irradiated autologous PBMCs. The SN45-derived TCR α and β cDNAs were cloned and transfected into TCRβ-deficient J.RT3 cells.","Figure 6","binding assay","qualitative binding",,http://purl.obolibrary.org/obo/OBI_1110124,Positive,,,,,,"The SN45 TCR tetramer bound to K562 cells transfected with Mamu-B*05104 and pulsed with the epitope. The SN45 TCR tetramer did not react with K562 cells transfected with Mamu-B*05104 and pulsed with the analog C14-GGGI.","Bone Marrow",http://purl.obolibrary.org/obo/UBERON_0002371,Lymphoblast,,Engineered,SN45,,,,,,,Mamu-B*051:04,http://purl.obolibrary.org/obo/MRO_0002141,"MHC binding assay",http://purl.obolibrary.org/obo/ECO_0008080,I,Epitope,"Linear peptide","GGAI + MYRI(G1)",,2,5,,"nef protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AQY14404.1,"Nef protein (Premature termination)",http://www.uniprot.org/uniprot/Q88019,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/6389606,http://www.iedb.org/reference/1036173,Literature,31711644,,"Hiroshi Ishii; Saori Matsuoka; Noriko Ikeda; Kyoko Kurihara; Takamasa Ueno; Masafumi Takiguchi; Taeko K Naruse; Akinori Kimura; Masaru Yokoyama; Hironori Sato; Tetsuro Matano","Biochem Biophys Res Commun",2020,"Determination of a T cell receptor of potent CD8&lt;sup&gt;+&lt;/sup&gt; T cells against simian immunodeficiency virus infection in Burmese rhesus macaques.",http://www.iedb.org/epitope/61432,"Linear peptide",SSVDEQIQW,Gag241-249,,,241,249,,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAW32412.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Simian immunodeficiency virus - mac  - mac 239",,,,,,,,,"Simian immunodeficiency virus - mac  - mac 239",https://ontology.iedb.org/taxon/10000501,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Lymphoblast,,Epitope,"Linear peptide",SSVDEQIQW,,241,249,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAW32412.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Epitope-specific CD8+ T-cells were derived from infected Manu-A1*065:01 positive animals. cDNAs encoding TCR variable region (V-J) were amplified. TG40 cells were then infected with the recombinant retroviruses to obtain cells expressing the epitope-specific TCR.","Figure 2",multimer/tetramer,"qualitative binding",,http://purl.obolibrary.org/obo/OBI_1110179,Positive-High,,,,,,"Epitope-specific TCR transfected CD8+ cells were tested.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Cell Line / Clone (Hybridoma)",TRA/TRB-SM9-01,,,,,,,Mamu-A1*065:01,http://purl.obolibrary.org/obo/MRO_0002196,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",SSVDEQIQW,,241,249,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAW32412.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/6467187,http://www.iedb.org/reference/1036173,Literature,31711644,,"Hiroshi Ishii; Saori Matsuoka; Noriko Ikeda; Kyoko Kurihara; Takamasa Ueno; Masafumi Takiguchi; Taeko K Naruse; Akinori Kimura; Masaru Yokoyama; Hironori Sato; Tetsuro Matano","Biochem Biophys Res Commun",2020,"Determination of a T cell receptor of potent CD8&lt;sup&gt;+&lt;/sup&gt; T cells against simian immunodeficiency virus infection in Burmese rhesus macaques.",http://www.iedb.org/epitope/61432,"Linear peptide",SSVDEQIQW,Gag241-249,,,241,249,,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAW32412.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Taxonomic Child",Organism,"Simian immunodeficiency virus - mac  - mac 239",,,,,,,,,"Simian immunodeficiency virus - mac  - mac 239",https://ontology.iedb.org/taxon/10000501,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Lymphoblast,,Epitope,"Linear peptide",SSVDEQIQW,,241,249,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAW32412.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Epitope-specific CD8+ T-cells were derived from infected Manu-A1*065:01 positive animals. cDNAs encoding TCR variable region (V-J) were amplified. TG40 cells were then infected with the recombinant retroviruses to obtain cells expressing the epitope-specific TCR.","Figure 2",ELISA,"IL-2 release",,http://purl.obolibrary.org/obo/OBI_1110152,Positive,,,,,,"Epitope-specific TCR transfected CD8+ cells were tested.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Cell Line / Clone (Hybridoma)",TRA/TRB-SM9-01,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)",Mamu-A1*065:01,http://purl.obolibrary.org/obo/MRO_0002196,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",SSVDEQIQW,,241,249,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAW32412.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/6480585,http://www.iedb.org/reference/1036173,Literature,31711644,,"Hiroshi Ishii; Saori Matsuoka; Noriko Ikeda; Kyoko Kurihara; Takamasa Ueno; Masafumi Takiguchi; Taeko K Naruse; Akinori Kimura; Masaru Yokoyama; Hironori Sato; Tetsuro Matano","Biochem Biophys Res Commun",2020,"Determination of a T cell receptor of potent CD8&lt;sup&gt;+&lt;/sup&gt; T cells against simian immunodeficiency virus infection in Burmese rhesus macaques.",http://www.iedb.org/epitope/981224,"Linear peptide",SSADEQIQW,"Gag V243A",,,241,249,,,"gag protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAU94511.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,"Administration in vivo",,,,"Structurally Related",Organism,"Simian immunodeficiency virus - mac  - mac 239",,,,,,,,,"Simian immunodeficiency virus - mac  - mac 239",https://ontology.iedb.org/taxon/10000501,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,"Restimulation in vitro",PBMC,http://purl.obolibrary.org/obo/CL_2000001,Lymphoblast,,"Structurally Related","Linear peptide",SSVDEQIQW,,241,249,,"gag protein",http://www.ncbi.nlm.nih.gov/protein/AAW32412.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,N,,"Wild type peptide-specific CD8+ T-cells were derived from infected Manu-A1*065:01 positive animals. cDNAs encoding TCR variable region (V-J) were amplified. TG40 cells were then infected with the recombinant retroviruses to obtain cells expressing the wild type peptide-specific TCR.","Figure 3",ELISA,"IL-2 release",,http://purl.obolibrary.org/obo/OBI_1110152,Positive-Low,,,,,,"Wild-type peptide-specific TCR transfected CD8+ cells were tested.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Cell Line / Clone (Hybridoma)",TRA-SM9-01/TRB-SM9-01,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,"B cell",http://purl.obolibrary.org/obo/CL_0000236,"Cell Line / Clone (EBV transformed, B-LCL)",Mamu-A1*065:01,http://purl.obolibrary.org/obo/MRO_0002196,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",SSADEQIQW,,241,249,,"gag protein [Simian immunodeficiency virus]",http://www.ncbi.nlm.nih.gov/protein/AAU94511.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/22752399,http://www.iedb.org/reference/1033653,Literature,29915023,,"Kelly D Moynihan; Rebecca L Holden; Naveen K Mehta; Chensu Wang; Mark R Karver; Jens Dinter; Simon Liang; Wuhbet Abraham; Mariane B Melo; Angela Q Zhang; Na Li; Sylvie Le Gall; Bradley L Pentelute; Darrell J Irvine","Cancer Immunol Res",2018,"Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability.",http://www.iedb.org/epitope/226820,"Linear peptide",AAVKNWMTQTL,AL11,,,312,322,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05893.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus - mac K6W",http://purl.obolibrary.org/obo/NCBITaxon_11735,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Mus musculus C57BL/6",https://ontology.iedb.org/ontology/ONTIE_0000062,,,,,,"Administration in vivo",,,,Epitope,"Linear peptide",AAVKNWMTQTL,DSPE-PEG-AL11,312,322,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05893.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus - mac K6W",http://purl.obolibrary.org/obo/NCBITaxon_11735,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"Animals were immunized with the free epitope, or with the epitope conjugated to a DSPE phospholipid tail through a poly(ethylene glycol) spacer (DSPE-PEG-AL11).","Figure S4",ICS,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110172,Positive,,,5,5,,"Cytokine production was significantly higher after immunization with DSPE-PEG-AL11 compared to the free epitope.","Lymph Node",http://purl.obolibrary.org/obo/UBERON_0000029,"T cell CD8+",http://purl.obolibrary.org/obo/CL_0000625,"Direct Ex Vivo",,,"Lymph Node",http://purl.obolibrary.org/obo/UBERON_0000029,"Lymph node cells",http://purl.obolibrary.org/obo/OBI_1110041,"Direct Ex Vivo","HLA class I",http://purl.obolibrary.org/obo/MRO_0001454,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",AAVKNWMTQTL,,312,322,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P05893.1,"Gag polyprotein",http://www.uniprot.org/uniprot/Q5QGH1,"Simian immunodeficiency virus - mac K6W",http://purl.obolibrary.org/obo/NCBITaxon_11735,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/22788727,http://www.iedb.org/reference/1043723,Literature,35970920,,"Christine D Palmer; Amy R Rappaport; Matthew J Davis; Meghan G Hart; Ciaran D Scallan; Sue-Jean Hong; Leonid Gitlin; Lauren D Kraemer; Sonia Kounlavouth; Aaron Yang; Lindsey Smith; Desiree Schenk; Mojca Skoberne; Kiara Taquechel; Martina Marrali; Jason R Jaroslavsky; Charmaine N Nganje; Elizabeth Maloney; Rita Zhou; Daniel Navarro-Gomez; Adrienne C Greene; Gijsbert Grotenbreg; Renee Greer; Wade Blair; Minh Duc Cao; Shawn Chan; Kyounghwa Bae; Alexander I Spira; Sameek Roychowdhury; David P Carbone; Brian S Henick; Charles G Drake; Benjamin J Solomon; Daniel H Ahn; Amit Mahipal; Steve B Maron; Benny Johnson; Raphael Rousseau; Roman Yelensky; Chih-Yi Liao; Daniel V T Catenacci; Andrew Allen; Andrew R Ferguson; Karin Jooss","Nat Med",2022,"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.",http://www.iedb.org/epitope/7197,"Linear peptide",CTPYDINQM,"SIV  Gag CM9",,,182,190,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P18041.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P18095,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,Vaccination,,,,"Fragment of Source Antigen","Linear peptide",GFQALSEGCTPYDINQMLNCVGDHQ,,174,198,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P18041.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P18095,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A model antigen cassette containing six NHP-specific MAMU-A*01-restricted SIV viral epitopes (SIV Gag CM9, SIV Env TL9, SIV Env CL9, SIV Tat TL8, SIV Gag LW9 and SIV Pol SV9) was designed. Each minimal epitope, including the epitope, is embedded in a 25 amino acid sequence with 8 amino acids flanking each minimal epitope sequence and inserted into the ChAd68 and samRNA vaccine platforms. The cassette also contains class II helper epitopes. MAMU-A*01-positive rhesus macaques were immunized intramuscularly (i.m.) with 10^12 VP ChAd68 prime, followed by i.m. 300 µg samRNA boosts at 4, 12 and 20 weeks, with or without concomitant administration of s.c. anti-CTLA-4 antibody ipilimumab.","Figure 1 and Extended Data Figure 1",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"Immunization with the ChAd68 vaccine platform induced immune responses against all six antigens, including the epitope at week 4 +/- ipilimumab. Primed T cell responses were boosted following administration of samRNA, with T cell responses still detectable 32 weeks after prime in both groups.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",Mamu-A1*001:01,http://purl.obolibrary.org/obo/MRO_0001358,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",CTPYDINQM,,182,190,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P18041.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P18095,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/22788728,http://www.iedb.org/reference/1043723,Literature,35970920,,"Christine D Palmer; Amy R Rappaport; Matthew J Davis; Meghan G Hart; Ciaran D Scallan; Sue-Jean Hong; Leonid Gitlin; Lauren D Kraemer; Sonia Kounlavouth; Aaron Yang; Lindsey Smith; Desiree Schenk; Mojca Skoberne; Kiara Taquechel; Martina Marrali; Jason R Jaroslavsky; Charmaine N Nganje; Elizabeth Maloney; Rita Zhou; Daniel Navarro-Gomez; Adrienne C Greene; Gijsbert Grotenbreg; Renee Greer; Wade Blair; Minh Duc Cao; Shawn Chan; Kyounghwa Bae; Alexander I Spira; Sameek Roychowdhury; David P Carbone; Brian S Henick; Charles G Drake; Benjamin J Solomon; Daniel H Ahn; Amit Mahipal; Steve B Maron; Benny Johnson; Raphael Rousseau; Roman Yelensky; Chih-Yi Liao; Daniel V T Catenacci; Andrew Allen; Andrew R Ferguson; Karin Jooss","Nat Med",2022,"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.",http://www.iedb.org/epitope/67123,"Linear peptide",TVPWPNASL,"SIV Env TL9",,,622,630,,,"Envelope glycoprotein gp160 precursor",http://www.ncbi.nlm.nih.gov/protein/P05884.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,Vaccination,,,,"Fragment of Source Antigen","Linear peptide",AFRQVCHTTVPWPNASLTPDWNNDT,,614,638,,"Envelope glycoprotein gp160 precursor",http://www.ncbi.nlm.nih.gov/protein/P05884.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A model antigen cassette containing six NHP-specific MAMU-A*01-restricted SIV viral epitopes (SIV Gag CM9, SIV Env TL9, SIV Env CL9, SIV Tat TL8, SIV Gag LW9 and SIV Pol SV9) was designed. Each minimal epitope, including the epitope, is embedded in a 25 amino acid sequence with 8 amino acids flanking each minimal epitope sequence and inserted into the ChAd68 and samRNA vaccine platforms. The cassette also contains class II helper epitopes. MAMU-A*01-positive rhesus macaques were immunized intramuscularly (i.m.) with 10^12 VP ChAd68 prime, followed by i.m. 300 µg samRNA boosts at 4, 12 and 20 weeks, with or without concomitant administration of s.c. anti-CTLA-4 antibody ipilimumab.","Figure 1 and Extended Data Figure 1",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"Immunization with the ChAd68 vaccine platform induced immune responses against all six antigens, including the epitope at week 4 +/- ipilimumab. Primed T cell responses were boosted following administration of samRNA, with T cell responses still detectable 32 weeks after prime in both groups.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",Mamu-A1*001:01,http://purl.obolibrary.org/obo/MRO_0001358,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",TVPWPNASL,,622,630,,"Envelope glycoprotein gp160 precursor",http://www.ncbi.nlm.nih.gov/protein/P05884.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/22788729,http://www.iedb.org/reference/1043723,Literature,35970920,,"Christine D Palmer; Amy R Rappaport; Matthew J Davis; Meghan G Hart; Ciaran D Scallan; Sue-Jean Hong; Leonid Gitlin; Lauren D Kraemer; Sonia Kounlavouth; Aaron Yang; Lindsey Smith; Desiree Schenk; Mojca Skoberne; Kiara Taquechel; Martina Marrali; Jason R Jaroslavsky; Charmaine N Nganje; Elizabeth Maloney; Rita Zhou; Daniel Navarro-Gomez; Adrienne C Greene; Gijsbert Grotenbreg; Renee Greer; Wade Blair; Minh Duc Cao; Shawn Chan; Kyounghwa Bae; Alexander I Spira; Sameek Roychowdhury; David P Carbone; Brian S Henick; Charles G Drake; Benjamin J Solomon; Daniel H Ahn; Amit Mahipal; Steve B Maron; Benny Johnson; Raphael Rousseau; Roman Yelensky; Chih-Yi Liao; Daniel V T Catenacci; Andrew Allen; Andrew R Ferguson; Karin Jooss","Nat Med",2022,"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.",http://www.iedb.org/epitope/6019,"Linear peptide",CAPPGYALL,"SIV Env CL9",,,235,243,,,"Envelope glycoprotein gp160 precursor",http://www.ncbi.nlm.nih.gov/protein/P05884.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,Vaccination,,,,"Fragment of Source Antigen","Linear peptide",WDTIRFRYCAPPGYALLRCNDTNYS,,227,251,,"Envelope glycoprotein gp160 precursor",http://www.ncbi.nlm.nih.gov/protein/P05884.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A model antigen cassette containing six NHP-specific MAMU-A*01-restricted SIV viral epitopes (SIV Gag CM9, SIV Env TL9, SIV Env CL9, SIV Tat TL8, SIV Gag LW9 and SIV Pol SV9) was designed. Each minimal epitope, including the epitope, is embedded in a 25 amino acid sequence with 8 amino acids flanking each minimal epitope sequence and inserted into the ChAd68 and samRNA vaccine platforms. The cassette also contains class II helper epitopes. MAMU-A*01-positive rhesus macaques were immunized intramuscularly (i.m.) with 10^12 VP ChAd68 prime, followed by i.m. 300 µg samRNA boosts at 4, 12 and 20 weeks, with or without concomitant administration of s.c. anti-CTLA-4 antibody ipilimumab.","Figure 1 and Extended Data Figure 1",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"Immunization with the ChAd68 vaccine platform induced immune responses against all six antigens, including the epitope at week 4 +/- ipilimumab. Primed T cell responses were boosted following administration of samRNA, with T cell responses still detectable 32 weeks after prime in both groups.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",Mamu-A1*001:01,http://purl.obolibrary.org/obo/MRO_0001358,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",CAPPGYALL,,235,243,,"Envelope glycoprotein gp160 precursor",http://www.ncbi.nlm.nih.gov/protein/P05884.1,"Envelope glycoprotein gp160",http://www.uniprot.org/uniprot/E7CWP5,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/22788730,http://www.iedb.org/reference/1043723,Literature,35970920,,"Christine D Palmer; Amy R Rappaport; Matthew J Davis; Meghan G Hart; Ciaran D Scallan; Sue-Jean Hong; Leonid Gitlin; Lauren D Kraemer; Sonia Kounlavouth; Aaron Yang; Lindsey Smith; Desiree Schenk; Mojca Skoberne; Kiara Taquechel; Martina Marrali; Jason R Jaroslavsky; Charmaine N Nganje; Elizabeth Maloney; Rita Zhou; Daniel Navarro-Gomez; Adrienne C Greene; Gijsbert Grotenbreg; Renee Greer; Wade Blair; Minh Duc Cao; Shawn Chan; Kyounghwa Bae; Alexander I Spira; Sameek Roychowdhury; David P Carbone; Brian S Henick; Charles G Drake; Benjamin J Solomon; Daniel H Ahn; Amit Mahipal; Steve B Maron; Benny Johnson; Raphael Rousseau; Roman Yelensky; Chih-Yi Liao; Daniel V T Catenacci; Andrew Allen; Andrew R Ferguson; Karin Jooss","Nat Med",2022,"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.",http://www.iedb.org/epitope/66760,"Linear peptide",TTPESANL,"SIV Tat TL8",,,28,35,,,"Protein Tat",http://www.ncbi.nlm.nih.gov/protein/P05910.1,"Protein Tat",http://www.uniprot.org/uniprot/Q5QFY3,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,Vaccination,,,,"Fragment of Source Antigen","Linear peptide",SCILEADATTPESANLGEEILSQL,,20,43,,"Protein Tat",http://www.ncbi.nlm.nih.gov/protein/P05910.1,"Protein Tat",http://www.uniprot.org/uniprot/Q5QFY3,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A model antigen cassette containing six NHP-specific MAMU-A*01-restricted SIV viral epitopes (SIV Gag CM9, SIV Env TL9, SIV Env CL9, SIV Tat TL8, SIV Gag LW9 and SIV Pol SV9) was designed. Each minimal epitope, including the epitope, is embedded in a 25 amino acid sequence with 8 amino acids flanking each minimal epitope sequence and inserted into the ChAd68 and samRNA vaccine platforms. The cassette also contains class II helper epitopes. MAMU-A*01-positive rhesus macaques were immunized intramuscularly (i.m.) with 10^12 VP ChAd68 prime, followed by i.m. 300 µg samRNA boosts at 4, 12 and 20 weeks, with or without concomitant administration of s.c. anti-CTLA-4 antibody ipilimumab.","Figure 1 and Extended Data Figure 1",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"Immunization with the ChAd68 vaccine platform induced immune responses against all six antigens, including the epitope at week 4 +/- ipilimumab. Primed T cell responses were boosted following administration of samRNA, with T cell responses still detectable 32 weeks after prime in both groups.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",Mamu-A1*001:01,http://purl.obolibrary.org/obo/MRO_0001358,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",TTPESANL,,28,35,,"Protein Tat",http://www.ncbi.nlm.nih.gov/protein/P05910.1,"Protein Tat",http://www.uniprot.org/uniprot/Q5QFY3,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/22788731,http://www.iedb.org/reference/1043723,Literature,35970920,,"Christine D Palmer; Amy R Rappaport; Matthew J Davis; Meghan G Hart; Ciaran D Scallan; Sue-Jean Hong; Leonid Gitlin; Lauren D Kraemer; Sonia Kounlavouth; Aaron Yang; Lindsey Smith; Desiree Schenk; Mojca Skoberne; Kiara Taquechel; Martina Marrali; Jason R Jaroslavsky; Charmaine N Nganje; Elizabeth Maloney; Rita Zhou; Daniel Navarro-Gomez; Adrienne C Greene; Gijsbert Grotenbreg; Renee Greer; Wade Blair; Minh Duc Cao; Shawn Chan; Kyounghwa Bae; Alexander I Spira; Sameek Roychowdhury; David P Carbone; Brian S Henick; Charles G Drake; Benjamin J Solomon; Daniel H Ahn; Amit Mahipal; Steve B Maron; Benny Johnson; Raphael Rousseau; Roman Yelensky; Chih-Yi Liao; Daniel V T Catenacci; Andrew Allen; Andrew R Ferguson; Karin Jooss","Nat Med",2022,"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.",http://www.iedb.org/epitope/39573,"Linear peptide",LSPRTLNAW,"SIV Gag LW9",,,150,158,,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P18041.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P18095,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,Vaccination,,,,"Fragment of Source Antigen","Linear peptide",GGNYIHVPLSPRTLNAWVKLVEDKK,,142,166,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P18041.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P18095,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A model antigen cassette containing six NHP-specific MAMU-A*01-restricted SIV viral epitopes (SIV Gag CM9, SIV Env TL9, SIV Env CL9, SIV Tat TL8, SIV Gag LW9 and SIV Pol SV9) was designed. Each minimal epitope, including the epitope, is embedded in a 25 amino acid sequence with 8 amino acids flanking each minimal epitope sequence and inserted into the ChAd68 and samRNA vaccine platforms. The cassette also contains class II helper epitopes. MAMU-A*01-positive rhesus macaques were immunized intramuscularly (i.m.) with 10^12 VP ChAd68 prime, followed by i.m. 300 µg samRNA boosts at 4, 12 and 20 weeks, with or without concomitant administration of s.c. anti-CTLA-4 antibody ipilimumab.","Figure 1 and Extended Data Figure 1",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"Immunization with the ChAd68 vaccine platform induced immune responses against all six antigens, including the epitope at week 4 +/- ipilimumab. Primed T cell responses were boosted following administration of samRNA, with T cell responses still detectable 32 weeks after prime in both groups.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",Mamu-A1*001:01,http://purl.obolibrary.org/obo/MRO_0001358,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",LSPRTLNAW,,150,158,,"Gag polyprotein",http://www.ncbi.nlm.nih.gov/protein/P18041.3,"Gag polyprotein",http://www.uniprot.org/uniprot/P18095,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
http://www.iedb.org/assay/22788732,http://www.iedb.org/reference/1043723,Literature,35970920,,"Christine D Palmer; Amy R Rappaport; Matthew J Davis; Meghan G Hart; Ciaran D Scallan; Sue-Jean Hong; Leonid Gitlin; Lauren D Kraemer; Sonia Kounlavouth; Aaron Yang; Lindsey Smith; Desiree Schenk; Mojca Skoberne; Kiara Taquechel; Martina Marrali; Jason R Jaroslavsky; Charmaine N Nganje; Elizabeth Maloney; Rita Zhou; Daniel Navarro-Gomez; Adrienne C Greene; Gijsbert Grotenbreg; Renee Greer; Wade Blair; Minh Duc Cao; Shawn Chan; Kyounghwa Bae; Alexander I Spira; Sameek Roychowdhury; David P Carbone; Brian S Henick; Charles G Drake; Benjamin J Solomon; Daniel H Ahn; Amit Mahipal; Steve B Maron; Benny Johnson; Raphael Rousseau; Roman Yelensky; Chih-Yi Liao; Daniel V T Catenacci; Andrew Allen; Andrew R Ferguson; Karin Jooss","Nat Med",2022,"Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.",http://www.iedb.org/epitope/58173,"Linear peptide",SGPKTNIIV,"SIV Pol SV9",,,692,700,,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59906.1,"Pol polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q88016,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,"Macaca mulatta (rhesus macaque)",http://purl.obolibrary.org/obo/NCBITaxon_9544,,,,,,Vaccination,,,,"Fragment of Source Antigen","Linear peptide",AFLMALTDSGPKTNIIVDSQYVMGI,,684,708,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59906.1,"Pol polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q88016,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,N,,"A model antigen cassette containing six NHP-specific MAMU-A*01-restricted SIV viral epitopes (SIV Gag CM9, SIV Env TL9, SIV Env CL9, SIV Tat TL8, SIV Gag LW9 and SIV Pol SV9) was designed. Each minimal epitope, including the epitope, is embedded in a 25 amino acid sequence with 8 amino acids flanking each minimal epitope sequence and inserted into the ChAd68 and samRNA vaccine platforms. The cassette also contains class II helper epitopes. MAMU-A*01-positive rhesus macaques were immunized intramuscularly (i.m.) with 10^12 VP ChAd68 prime, followed by i.m. 300 µg samRNA boosts at 4, 12 and 20 weeks, with or without concomitant administration of s.c. anti-CTLA-4 antibody ipilimumab.","Figure 1 and Extended Data Figure 1",ELISPOT,"IFNg release",,http://purl.obolibrary.org/obo/OBI_1110059,Positive,,,,,,"Immunization with the ChAd68 vaccine platform induced immune responses against all six antigens, including the epitope at week 4 +/- ipilimumab. Primed T cell responses were boosted following administration of samRNA, with T cell responses still detectable 32 weeks after prime in both groups.",Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",,,Blood,http://purl.obolibrary.org/obo/UBERON_0000178,PBMC,http://purl.obolibrary.org/obo/CL_2000001,"Direct Ex Vivo",Mamu-A1*001:01,http://purl.obolibrary.org/obo/MRO_0001358,"Cited reference",http://purl.obolibrary.org/obo/ECO_0000304,I,Epitope,"Linear peptide",SGPKTNIIV,,692,700,,"pol polyprotein",http://www.ncbi.nlm.nih.gov/protein/AAB59906.1,"Pol polyprotein (Fragment)",http://www.uniprot.org/uniprot/Q88016,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723,"Simian immunodeficiency virus",http://purl.obolibrary.org/obo/NCBITaxon_11723
